| Gene ID |
Gene Name |
Sequence Strain (Species/Organism) |
VO ID |
NCBI Gene ID |
NCBI Nucleotide GI |
NCBI Protein GI |
Locus Tag |
Genbank Accession |
Protein Accession |
3D structure: PDB ID |
Other Database IDs |
Protein Name |
Molecule Role |
Vaccines Involving this Gene |
|
372
|
11C5 |
Babesia bovis T2Bo |
|
|
|
156086656
|
BBOV_IV008150 |
|
XP_001610737 |
|
|
|
Protective antigen |
|
|
371
|
12D3 |
Babesia bovis T2Bo |
VO_0011027
|
5478971
|
|
156086656
|
BBOV_IV008150 |
AAXT01000002 |
XP_001610737 |
|
|
|
Protective antigen |
B. bovis GST-12D3
|
|
1619
|
18H6 synthetic E protein |
synthetic construct |
|
|
73915390
|
73915391
|
|
|
AAZ92557.1 |
|
CDD:279241
CDD:280922
CDD:213897 |
chimeric Dengue envelope antigen 18H6 |
Protective antigen |
Dengue virus DNA vaccine sB encoding E
Dengue virus DNA vaccine sABC encoding prM and E
|
|
1664
|
1D |
Foot-and-mouth disease virus - type Asia 1 |
|
|
|
148800633
|
|
|
|
|
CDD:301302
CDD:119412 |
1D protein |
Protective antigen |
Foot-and-Mouth Disease Virus Cationic Microparticle-coated DNA Vaccine
Foot-and-Mouth Disease Virus DNA Vaccine pSinCMV-Vac-MEG990
|
|
1699
|
1D |
Foot-and-mouth disease virus - type O |
|
|
|
56675803
|
|
|
|
|
GOA:Q9DJ81
InterPro: IPR004080
UniProtKB/TrEMBL: Q9DJ81 |
VP1 |
Protective antigen |
Foot-and-Mouth Disease Virus DNA Vaccine pSinCMV-Vac-MEG990
|
|
1700
|
1D |
Foot-and-mouth disease virus - type A |
|
|
|
13399192
|
|
|
|
|
CDD:301302
CDD:119412
GOA:Q98VZ6
InterPro: IPR001676
InterPro: IPR004080
UniProtKB/TrEMBL: Q98VZ6 |
VP1 |
Protective antigen |
Foot-and-Mouth Disease Virus DNA Vaccine pSinCMV-Vac-MEG990
|
|
373
|
21B4 |
Babesia bovis |
VO_0011028
|
|
|
1246924
|
|
|
|
|
|
21B4 |
Protective antigen |
|
|
1409
|
26S |
Western equine encephalomyelitis virus |
|
|
|
7330241
|
|
|
|
|
CDD:279312
CDD:279849
CDD:279311
CDD:279870 |
structural polyprotein |
Protective antigen |
WEE virus DNA vaccine pVHX-6 encoding 26S
|
|
593
|
26S mRNA |
Venezuelan equine encephalitis virus |
|
2652924
|
|
9626528
|
VEEVgp3 |
AY973944 |
NP_040824 |
|
|
mRNA |
Protective antigen |
VEE virus DNA vaccine encoding 26S
|
|
165
|
26S mRNA from VEEV |
Venezuelan equine encephalitis virus |
|
2652924
|
|
9626528
|
VEEVgp3 |
NC_001449.1 |
NP_040824.1 |
|
|
structural polyprotein precursor |
|
Multivalent DNA vaccine for B. anthracis, Ebola virus, Marburg virus, and VEE virus
|
|
1695
|
2A |
Foot-and-mouth disease virus - type O |
|
|
|
25121634
|
|
|
|
|
|
2A |
Protective antigen |
FMDV DNA Vaccine encoding P1 and non-structural proteins 2A, 3C, and 3D
|
|
463
|
3-1E |
Eimeria tenella |
VO_0011066
|
|
|
126362934
|
|
|
|
|
CDD:320770
CDD:238085 |
sporozoite antigen 3-1E |
Protective antigen |
E. tenella DNA vaccine proIE
|
|
1689
|
3-1E |
Eimeria acervulina strain QH |
|
|
|
51234119
|
|
|
|
|
CDD:294086
CDD:238085 |
3-1E protein |
Protective antigen |
E. acervulina DNA vaccine 3-1E
|
|
1046
|
3a |
Feline infectious peritonitis virus |
|
10040181
|
|
315192965
|
FIPV_gp03 |
AY994055 |
YP_004070195 |
|
|
putative 3a protein |
Virmugen |
Feline infectiour peritonitis virus 3abc mutant vaccine
|
|
1047
|
3b |
Feline infectious peritonitis virus |
|
10040182
|
|
315192966
|
FIPV_gp04 |
AY994055 |
YP_004070196 |
|
|
putative 3b protein |
Virmugen |
Feline infectiour peritonitis virus 3abc mutant vaccine
|
|
1048
|
3c |
Feline infectious peritonitis virus |
|
10040183
|
|
|
FIPV_gp05 |
|
|
|
|
|
Virmugen |
Feline infectiour peritonitis virus 3abc mutant vaccine
|
|
1696
|
3C |
Foot-and-mouth disease virus - type O |
|
|
|
25121639
|
|
|
|
|
CDD:201298 |
3C |
Protective antigen |
FMDV DNA Vaccine encoding P1 and non-structural proteins 2A, 3C, and 3D
|
|
1697
|
3D |
Foot-and-mouth disease virus - type O |
|
|
|
25121640
|
|
|
|
|
CDD:73158 |
3D |
Protective antigen |
FMDV DNA Vaccine encoding P1 and non-structural proteins 2A, 3C, and 3D
|
|
4216
|
5'-nucleotidase family protein |
Streptococcus agalactiae |
|
|
|
ASZ01629
|
|
|
|
|
CDD:326311
CDD:277317
CDD:308488 |
5'-nucleotidase family protein |
Protective antigen |
|
|
775
|
6K |
Western equine encephalomyelitis virus |
VO_0011307
|
|
|
29611993
|
|
|
|
|
CDD:279870 |
6K protein |
Protective antigen |
WEEV DNA Vaccine encoding 6K-E1 Protein
|
|
4632
|
7299 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1049
|
7a |
Feline infectious peritonitis virus |
|
10040187
|
|
315192970
|
FIPV_gp09 |
AY994055 |
YP_004070200 |
|
|
non-structural protein 7a |
Virmugen |
Feline infectious peritonitis virus 7ab mutant vaccine
|
|
1050
|
7b |
Feline infectious peritonitis virus |
|
10040188
|
|
315192971
|
FIPV_gp10 |
AY994055 |
YP_004070201 |
|
|
non-structural protein 7b |
Virmugen |
Feline infectious peritonitis virus 7ab mutant vaccine
|
|
2393
|
85-B |
Mycobacterium bovis strain 1173P2 |
|
|
|
44168
|
|
|
|
|
CDD:223700
GOA:A1KJU9
InterPro: IPR000801
UniProtKB/UniProt: A1KJU9 |
protein or antigen 85-B |
Protective antigen |
M. bovis DNA vaccine pCI-Ag85B
|
|
1100
|
9GL |
African swine fever virus Mal |
|
|
|
6759635
|
|
|
|
|
CDD:194250 |
Mal-9GL protein |
Virmugen |
African Swine Fever Virus 9GL mutant vaccine
|
|
563
|
A2 |
Leishmania donovani |
VO_0011153
|
|
|
30385439
|
|
|
|
|
|
stage-specific S antigen-like protein |
Protective antigen |
Leishmania vaccine using recombinant L. tarentolae strain expressing A2 antigen
|
|
68
|
A21L |
Vaccinia virus |
VO_0012363
|
3707670
|
|
66275937
|
VACWR140 |
AY603355 |
YP_233022 |
|
|
IMV membrane protein |
Protective antigen |
LC16m8
|
|
29
|
A27L |
Monkeypox virus (strain: Zaire-96-I-16) |
|
928973
|
|
|
MPXVgp137 |
|
|
|
|
|
|
Smallpox DNA Vaccine
|
|
1404
|
A27L |
Vaccinia virus |
|
3707680
|
|
66275947
|
VACWR150 |
AY160184 |
YP_233032 |
|
|
IMV surface protein |
Protective antigen |
Vaccinia virus DNA vaccine 4pox
|
|
1624
|
A27L |
Vaccinia virus strain Connaught |
|
|
|
58177828
|
|
|
|
|
CDD:111257 |
A27L |
Other |
|
|
4261
|
A30L |
Variola virus |
|
|
|
CAA47504
|
|
|
|
|
CDD:283633
InterPro: IPR009257
UniProtKB/UniProt: P68597 |
A30L |
Protective antigen |
|
|
1399
|
A33R |
Vaccinia virus |
|
3707686
|
|
66275953
|
VACWR156 |
AF226618 |
YP_233038 |
|
|
EEV membrane phosphoglycoprotein |
Protective antigen |
Vaccinia virus DNA vaccine A33R from strain IHD-J
|
|
1626
|
A33R |
Vaccinia virus strain Connaught |
|
|
|
7546900
|
|
|
|
|
CDD:222979 |
A33R |
Protective antigen |
Vaccinia virus DNA vaccine 4pox
|
|
30
|
A33R from Monkeypox virus (strain: Zaire-96-I-16) |
Monkeypox virus (strain: Zaire-96-I-16) |
|
928961
|
|
|
MPXVgp143 |
|
|
|
|
|
|
Smallpox DNA Vaccine
|
|
57
|
A33R from Vaccinia virus (strain: WR (Western Reserve)) |
Vaccinia virus (strain: WR (Western Reserve)) |
|
3707686
|
|
|
VACWR156 |
NC_006998 |
|
|
|
|
|
IMV-EEV
LC16m8
|
|
59
|
A34R |
Vaccinia virus (strain: WR (Western Reserve)) |
|
3707687
|
|
|
VACWR157 |
NC_006998 |
|
|
|
|
|
IMV-EEV
LC16m8
|
|
1400
|
A34R |
Vaccinia virus |
|
3707687
|
|
66275954
|
VACWR157 |
A19583 |
YP_233039 |
|
|
IEV and EEV membrane glycoprotein |
Protective antigen |
|
|
60
|
A36R |
Variola virus |
|
3707689
|
|
|
VACWR159 |
|
|
|
|
|
|
IMV-EEV
LC16m8
|
|
1401
|
A36R |
Vaccinia virus |
|
3707689
|
|
66275956
|
VACWR159 |
D11079 |
YP_233041 |
|
|
IEV transmembrane phosphoprotein |
Protective antigen |
|
|
1406
|
A4L |
Vaccinia virus |
|
3707521
|
|
66275920
|
VACWR123 |
S71673 |
YP_233005 |
|
|
39kDa core protein |
Protective antigen |
|
|
66
|
A56R |
Vaccinia virus (strain: WR (Western Reserve)) |
|
3707652
|
|
|
VACWR181 |
|
|
|
|
|
|
LC16m8
|
|
4527
|
AAV2gp02 |
Adeno-associated virus - 2 |
|
1489608
|
|
110645918
|
AAV2gp02 |
AF043303 |
YP_680423 |
|
|
Rep 78 protein |
Protective antigen |
|
|
4672
|
ABALON |
Homo sapiens |
|
103021294
|
|
|
|
AL160175 |
|
|
|
apoptotic BCL2L1-antisense long non-coding RNA |
Protective antigen |
|
|
4460
|
ABL2 |
Homo sapiens |
|
27
|
|
209862772
|
|
AL139132 |
NP_001129472 |
|
|
transcript variant X4 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
|
|
137
|
ABRA |
Plasmodium falciparum Camp |
VO_0010926
|
|
|
160047
|
|
|
|
|
swissprot:: P22620; GI:113005 |
p101/acidic basic repeat antigen |
Protective antigen |
Recombinant ABRA protein vaccine
|
|
4562
|
ACP3 |
Homo sapiens |
|
55
|
|
6382064
|
|
AC020633 |
NP_001090 |
|
|
transcript variant X2 |
Protective antigen |
MVA-PSA/PAP Prostate Cancer Vaccine
Sipuleucel-T
|
|
702
|
ACPP |
Homo sapiens |
|
55
|
|
6382064
|
|
AC020633 |
NP_001090 |
1CVI
|
|
transcript variant 2 |
Protective antigen |
PSA-PAP/KLH-pulsed Autologous Dendritic Cell Vaccine
APC8015F
|
|
921
|
actA |
Listeria monocytogenes EGD-e |
|
987035
|
|
16802250
|
lmo0204 |
AL591974 |
NP_463735 |
1EVH
|
|
actin-assembly inducing protein precursor |
Virmugen |
Listeria monocytogenes actA mutant vaccine
Listeria monocytogenes actA/plcB mutant vaccine
|
|
4459
|
ADAM17 |
Homo sapiens |
|
6868
|
|
1843978386
|
|
AB034151 |
NP_001369706 |
|
|
transcript variant 1 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
IMT-1012 Immunotherapeutic Vaccine
|
|
3869
|
ADP,ATP carrier protein |
Rickettsia prowazekii str |
|
|
|
NP_221091
|
|
|
|
|
CDD:281244 |
ADP,ATP carrier protein |
Protective antigen |
|
|
3872
|
adr2 |
Rickettsia prowazekii str. |
|
|
|
ADE30402
|
|
|
|
|
CDD:226163 |
Rickettsia adhesin |
Protective antigen |
|
|
315
|
AFP |
Homo sapiens |
|
174
|
|
4501989
|
|
AC108157 |
NP_001125 |
|
|
transcript variant 1 |
Protective antigen |
Alpha Fetoprotein Plasmid DNA Vaccine
AFP Gene Hepatocellular Carcinoma Vaccine
Alpha Fetoprotein Adenoviral Vector Vaccine
Autologous Colorectal Tumor Antigen-pulsed Dendritic Cell Vaccine
Cytokine-Induced Killer Cells
Alpha-fetoprotein Peptide-Pulsed Autologous Dendritic Cell Vaccine
|
|
3822
|
AFP from human-Obsolete |
Homo sapiens |
|
174
|
|
4501989
|
|
AC108157 |
NP_001125 |
|
|
transcript variant 1 |
Protective antigen |
Alpha Fetoprotein Adenoviral Vector Vaccine
|
|
4464
|
ag85A |
Mycobacterium tuberculosis H37Rv |
|
23489907
|
|
489997754
|
RVBD_RS20065 |
AL123456 |
WP_003900759 |
|
|
diacylglycerol acyltransferase/mycolyltransferase Ag85A |
Protective antigen |
TICE BCG
|
|
118
|
Ag85B from M. tuberculosis H37Rv |
Mycobacterium tuberculosis H37Rv |
VO_0012364
|
885785
|
|
15609023
|
Rv1886c |
AL123456 |
NP_216402 |
|
EMBL: AE000516
EMBL: AF198032
EMBL: BX842578
EMBL: U38939
EMBL: X62398
GenomeReviews: AE000516_GR
GenomeReviews: AL123456_GR
InterPro: IPR000801
KEGG: mtc:MT1934
KEGG: mtu:Rv1886c
PDB: 1F0N
PDB: 1F0P
Pfam: PF00756
PIR: C70516
TIGR: MT1934
TubercuList: Rv1886c
UniProt: P31952 |
diacylglycerol acyltransferase/mycolyltransferase Ag85B |
Protective antigen |
Arabinomannan-tetanus toxoid conjugate
Ag85B and ESAT-6 fusion protein
M. tuberculosis DNA Vaccine encoding Ag85B Protein
MVA/IL-15/5Mtb vaccine
M. tuberculosis DNA vaccine encoding Ag85B, MPT64 and MPT83
rBCG-Ag85A/ Ag85B
LT-BCG- Ag85B /Rv3425
|
|
4451
|
AIM2 |
Homo sapiens |
|
9447
|
|
1134787082
|
|
AL035403 |
NP_001335176 |
|
|
transcript variant X2 |
Protective antigen |
AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
|
|
4385
|
Ak1 |
Schistosoma japonicum |
|
|
|
CAX82987
|
|
|
|
|
CDD:130427
CDD:238713
GOA:Q86BY2
HSSP: 3ADK
InterPro: IPR000850
UniProtKB/TrEMBL: Q86BY2 |
adenylate kinase 1 |
Protective antigen |
|
|
4763
|
AKAP4 |
Homo sapiens |
|
8852
|
|
21493037
|
|
AC235789 |
NP_003877 |
|
|
transcript variant 1 |
Protective antigen |
Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
|
|
4601
|
AKT1 |
Homo sapiens |
|
207
|
|
62241013
|
|
A62733 |
NP_001014431 |
|
|
transcript variant X1 |
Protective antigen |
RCAS-Akt
|
|
4210
|
aldehyde dehydrogenase |
Streptococcus agalactiae |
|
|
|
OZV86763
|
|
|
|
|
|
aldehyde dehydrogenase |
Protective antigen |
|
|
4678
|
ALDH1A1 |
Homo sapiens |
|
216
|
|
21361176
|
|
AH002598 |
NP_000680 |
|
|
aldehyde dehydrogenase 1 family member A1 |
Protective antigen |
Autologous Pluripotent ALDHbr Stem Cells ALD-451
Allogeneic Melanoma Vaccine AGI-101H
|
|
4679
|
ALDH2 |
Homo sapiens |
|
217
|
|
25777732
|
|
AC002996 |
NP_000681 |
|
|
transcript variant 1 |
Protective antigen |
Autologous Pluripotent ALDHbr Stem Cells ALD-451
|
|
3884
|
algE |
Pseudomonas aeruginosa |
|
|
|
NP_252234
|
|
|
|
|
CDD:315937 |
alginate production protein AlgE |
Protective antigen |
|
|
3926
|
Alkyl hydroperoxide reductase(AhpC) |
Helicobacter pylori |
|
|
|
EIE30837
|
|
|
|
|
|
Alkyl hydroperoxide reductase |
Protective antigen |
|
|
4218
|
alp1 |
Streptococcus agalactiae |
|
|
|
AAR08144
|
|
|
|
|
CDD:282500
CDD:204077
CDD:131384
CDD:298076 |
alpha-like protein 1 |
Protective antigen |
|
|
4219
|
alp3 |
Streptococcus agalactiae |
|
|
|
AKI94854
|
|
|
|
|
CDD:309682
CDD:312387
CDD:131384
CDD:307064 |
Alpha-like protein 3 |
Protective antigen |
|
|
4843
|
alpha-enolase |
Homo sapiens |
|
2023
|
|
319996655
|
|
AL139415 |
NP_001188412 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4842
|
alpha1-giardin |
Giardia intestinalis |
|
5697168
|
|
159108073
|
GL50803_0011654 |
AACB03000003 |
XP_001704310 |
|
|
|
Protective antigen |
G. lamblia bivalent DNA vaccine encoding a1-giardin and CWP2
|
|
653
|
AMA-1 |
Plasmodium chabaudi |
VO_0011237
|
|
|
1469500
|
|
|
|
|
CDD:302876 |
apical membrane antigen 1 |
Protective antigen |
P. chabaudi AMA1 Protein Vaccine
|
|
640
|
AMA-1 from P. berghei |
Plasmodium berghei |
VO_0011224
|
|
|
1438889
|
|
|
|
|
CDD:280571 |
apical membrane antigen-1 |
Protective antigen |
|
|
139
|
AMA1 from P. falciparum 3D7 |
Plasmodium falciparum 3D7 |
VO_0010923
|
810891
|
|
124804478
|
PF3D7_1133400 |
LN999945 |
XP_001348015 |
1Z40
|
UniProt: P22621 |
Apical membrane antigen 1 (AMA1); PF11_0344; AMA-1, Pf83, RMA1, RMA 1, rhoptry membrane antigen |
Protective antigen |
FMP1/AS02A
ChAd63-MVA AMA1
|
|
1745
|
AMA1 from P. knowlesi |
Plasmodium knowlesi strain H |
|
|
|
221056402
|
|
|
|
|
CDD:240241
EnsemblGenomes-Gn:PKH_093110
EnsemblGenomes-Tr:PKH_093110
GOA:B3L5E1
InterPro: IPR003298
InterPro: IPR024056
UniProtKB/TrEMBL: B3L5E1 |
apical merozoite antigen 1 |
Protective antigen |
P. knowlesi DNA vaccine encoding PkCSP, PkSSP2, PkAMA1, and PkMSP1p42
|
|
752
|
amastigote surface protein-2 |
|
VO_0011289
|
|
|
284180153
|
|
|
|
|
CDD:240366
CDD:271234 |
amastigote surface protein-2 |
Protective antigen |
T. cruzi vaccine using Sendai virus vector expressing amastigote surface protein-2
T. cruzi DNA vaccine encoding TSA-1, ASP-1, ASP-2
T. cruzi DNA vaccine encoding ASP-2
T. cruzi DNA vaccine pUB-ASP-2
|
|
797
|
AMN1 |
Coccidioides posadasii |
VO_0011328
|
|
|
76786276
|
|
|
|
|
CDD:279825 |
alpha-mannosidase 1 |
Protective antigen |
|
|
494
|
ANDVsSgp1 |
Andes orthohantavirus |
VO_0011092
|
991232
|
|
19744950
|
ANDVsSgp1 |
AF004660 |
NP_604471 |
|
|
nucleocapsid protein |
Protective antigen |
Andes virus vaccine using adenovirus viral vector expressing ANDV NP
|
|
687
|
Angpt1 |
Mus musculus |
|
11600
|
|
555290158
|
|
AC100734 |
NP_001272991 |
|
|
transcript variant 2 |
Protective antigen |
|
|
4024
|
ankyrin repeat domain protein |
Coxiella burnetii Q321] |
|
|
|
EDR36478
|
|
|
|
|
|
ankyrin repeat domain protein |
Protective antigen |
|
|
300
|
ANTXR1 |
Homo sapiens |
|
84168
|
|
16933553
|
|
AC112230 |
NP_060623 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4084
|
aopX |
Aeromonas salmonicida subsp. |
|
|
|
ACK98975
|
|
|
|
|
|
putative T3SS effector AopX |
Protective antigen |
|
|
588
|
Apa |
Mycobacterium tuberculosis H37Rv |
VO_0011175
|
885896
|
|
57116926
|
Rv1860 |
AL123456 |
YP_177849 |
|
|
hypothetical protein |
Protective antigen |
M. tuberculosis DNA Vaccine APADNA priming and APAMVA boosting
|
|
4092
|
apfA |
Actinobacillus pleuropneumoniae |
|
|
|
AAO64346
|
|
|
|
|
CDD:331644 |
major type IV fimbrial subunit precursor |
Protective antigen |
A. pleuropneumoniae apfA vaccine
|
|
362
|
APP7_1016 |
Actinobacillus pleuropneumoniae serovar 7 str. AP76 |
VO_0011022
|
6398034
|
|
190150285
|
APP7_1016 |
CP001091 |
YP_001968810 |
|
|
hemolysin activator protein |
Protective antigen |
|
|
940
|
apxIA |
Actinobacillus pleuropneumoniae L20 |
|
4850247
|
|
126208908
|
APL_1444 |
CP000569 |
YP_001054133 |
|
|
RTX-I toxin determinant A |
Virmugen |
Actinobacillus pleuropneumoniae apxIA mutant vaccine
|
|
358
|
apxIA |
Actinobacillus pleuropneumoniae |
VO_0011019
|
|
|
312899
|
|
|
|
|
CDD:308152
CDD:225483
CDD:311996
GOA:P55128
InterPro: IPR001343
InterPro: IPR003995
InterPro: IPR011049
InterPro: IPR013550
InterPro: IPR018504
InterPro: IPR018511
UniProtKB/UniProt: P55128 |
|
Protective antigen |
A. pleuropneumoniae ApxIA protein vaccine
A. pleuropneumoniae ApxIa and ApxIIa protein vaccine
A. pleuropneumoniae DNA vaccine pcDNA-apxIA/pcDNA-apxIIA
HS93Tox-/pIG-T1K
rS.C-APP-ApxI/ApxII
mixture of Salmonella strains delivering ApxIA, ApxIIA, ApxIIIA and OmpA of A. pleuropneumoniae
|
|
402
|
ApxIC |
Actinobacillus pleuropneumoniae |
|
|
|
1477456
|
|
|
|
|
CDD:154216 |
|
Virmugen |
Actinobacillus pleuropneumoniae ApxIC mutant vaccine
|
|
360
|
apxIIA |
Actinobacillus pleuropneumoniae |
VO_0011020
|
|
|
52630374
|
|
|
|
|
CDD:280531
CDD:225483
CDD:305016
CDD:285531 |
ApxIIA |
Protective antigen |
A. pleuropneumoniae ApxIa and ApxIIa protein vaccine
A. pleuropneumoniae DNA vaccine pcDNA-apxIA/pcDNA-apxIIA
rS.C-APP-ApxI/ApxII
mixture of Salmonella strains delivering ApxIA, ApxIIA, ApxIIIA and OmpA of A. pleuropneumoniae
|
|
1037
|
apxIIA |
Actinobacillus pleuropneumoniae serotype 2 |
|
|
|
255959000
|
APL_0956 |
CP000569 |
YP_001053657 |
|
CDD:111291
CDD:116920 |
RTX-II toxin determinant A |
Virmugen |
Actinobacillus pleuropneumoniae ureC and apxIIA double mutant deletion vaccine
rS.C-APP-ApxIIA
|
|
401
|
ApxIIC |
Actinobacillus pleuropneumoniae |
|
|
|
52630373
|
|
|
|
|
CDD:154216 |
ApxIIC |
Virmugen |
A. pleuropneumoniae HS93C-Ampr
Actinobacillus pleuropneumoniae apxIIC and apxIVA double deletion mutant vaccine
|
|
4088
|
apxIIIA |
Actinobacillus pleuropneumoniae |
|
|
|
CAA48711
|
|
|
|
|
CDD:308152
CDD:225483
CDD:311996
GOA:P55131
InterPro: IPR001343
InterPro: IPR003995
InterPro: IPR011049
InterPro: IPR013550
InterPro: IPR018504
InterPro: IPR018511
UniProtKB/UniProt: P55131 |
ApxIIIA |
Protective antigen |
mixture of Salmonella strains delivering ApxIA, ApxIIA, ApxIIIA and OmpA of A. pleuropneumoniae
|
|
975
|
apxIIIB |
Actinobacillus pleuropneumoniae serovar 2 |
|
|
470686
|
|
|
|
|
|
CDD:30270
CDD:162558
CDD:186074
CDD:73011 |
RTX toxin |
Virmugen |
Actinobacillus pleuropneumoniae apxIIIB and apxIIID double mutant vaccine
|
|
977
|
apxIIID |
Actinobacillus pleuropneumoniae serovar 2 |
|
|
470687
|
|
|
|
|
|
CDD:130902 |
RTX toxin |
Virmugen |
Actinobacillus pleuropneumoniae apxIIIB and apxIIID double mutant vaccine
|
|
405
|
ApxIVA |
Actinobacillus pleuropneumoniae |
|
|
|
6671152
|
|
|
|
|
CDD:164328
CDD:116920 |
ApxIVA |
Virmugen |
Actinobacillus pleuropneumoniae apxIIC and apxIVA double deletion mutant vaccine
|
|
4724
|
AR |
Homo sapiens |
|
367
|
|
21322252
|
|
AF159087 |
NP_000035 |
|
|
transcript variant 1 |
Protective antigen |
Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118
|
|
4215
|
argF |
Streptococcus agalactiae |
|
|
|
AMQ15599
|
|
|
|
|
CDD:235269 |
Ornithine carbamoyltransferase |
Protective antigen |
|
|
188
|
aroA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
197
|
AroA |
Shigella flexneri 2a str. 2457T |
|
1077373
|
|
30062442
|
S0967 |
NC_004741.1 |
NP_836613.1 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
S. flexneri 2a strain CVD 1203
S. dysenteriae 1 strain WRSd1
S. sonnei strain WRSS1
CVD 1204(pGA1-CS2)
S. flexneri EcSf2a-1 containing shigella plasmid in E. Coli vector
|
|
878
|
aroA |
Staphylococcus aureus subsp. aureus ED98 |
|
8614197
|
|
269203089
|
SAAV_1451 |
CP001781 |
YP_003282358 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
Staphylococcus aureus aroA mutant vaccine
|
|
889
|
aroA |
Salmonella enterica subsp. enterica serovar Typhi str. Ty2 |
|
1068996
|
|
29142379
|
t1956 |
AE014613 |
NP_805721 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
Salmonella typhi aroA mutant vaccine
|
|
897
|
aroA |
|
|
|
|
15420539
|
|
|
|
|
CDD:179423
CDD:30129 |
5-enolpyruvylshikimate-3-phosphate synthase |
Virmugen |
Yersinia ruckeri aroA mutant vaccine
|
|
898
|
aroA |
|
|
|
|
144037
|
|
|
|
|
CDD:179423
CDD:30129 |
|
Virmugen |
Bordetella pertussis aroA mutant vaccine
|
|
900
|
aroA |
Yersinia enterocolitica subsp. enterocolitica 8081 |
|
4713234
|
|
123441850
|
YE1538 |
AM286415 |
YP_001005833 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
Yersinia enterocolitica aroA mutant vaccine
|
|
902
|
aroA |
Bordetella bronchiseptica RB50 |
|
2659145
|
|
33602442
|
BB3469 |
BX640447 |
NP_890002 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
Bordetella bronchiseptica aroA mutant vaccine (strain BBS18)
Bordetella bronchiseptica aroA/trpE mutant vaccine
|
|
916
|
aroA |
|
|
|
|
581456
|
|
|
|
|
CDD:179423
CDD:30129
GOA:Q04570
InterPro: IPR001986
InterPro: IPR006264
InterPro: IPR013792
InterPro: IPR023193
UniProtKB/UniProt: Q04570 |
|
Virmugen |
Pasteurella multocida aroA mutant vaccine
|
|
920
|
aroA |
M. haemolytica NADC-D60 |
|
|
|
451485
|
|
|
|
|
CDD:179423
CDD:30129 |
5-enolpyruvylshikimate 3-phosphate synthase |
Virmugen |
Mannheimia haemolytica aroA mutant vaccine
|
|
942
|
aroA |
Aeromonas salmonicida subsp. salmonicida A449 |
|
4997369
|
|
145298842
|
ASA_1859 |
CP000644 |
YP_001141683 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
A. salmonicida live-attenuated vaccine encoding AroA
|
|
333
|
aroa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
366
|
aroA |
Aeromonas salmonicida |
VO_0011024
|
|
|
512545
|
|
|
|
|
GOA:Q03321
UniProtKB/UniProt: Q03321 |
|
Protective antigen |
A. salmonicida live-attenuated vaccine encoding AroA
|
|
689
|
AroA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1060
|
aroA |
Aeromonas hydrophila subsp. hydrophila ATCC 7966 |
|
4489425
|
|
117619998
|
AHA_1979 |
CP000462 |
YP_856510 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
Aeromonas hydrophila aroA mutant vaccine
|
|
182
|
AroC |
Salmonella enterica subsp. enterica serovar Typhi Ty2 |
|
1069415
|
|
29140996
|
t0480 |
NC_004631.1 |
NP_804338.1 |
|
|
chorismate synthase |
Virmugen |
Aro-deleted S. Typhi
CVD 908-htrA
|
|
918
|
aroC |
Burkholderia pseudomallei 1106a |
|
4899749
|
|
126453136
|
BURPS1106A_1713 |
CP000572 |
YP_001065984 |
|
|
chorismate synthase |
Virmugen |
Burkholderia pseudomallei aroC deletion mutant vaccine
|
|
1091
|
aroC |
Edwardsiella tarda EIB202 |
|
8608790
|
|
269139790
|
ETAE_2445 |
CP001135 |
YP_003296491 |
|
|
chorismate synthase |
Virmugen |
Edwardsiella tarda aroC mutant vaccine
Edwardsiella tarda aroC/esrC mutant vaccine
|
|
181
|
AroD |
Salmonella enterica subsp. enterica serovar Typhi Ty2 |
|
1070649
|
|
29141695
|
t1231 |
NC_004631.1 |
NP_805037.1 |
1QFE
|
|
3-dehydroquinate dehydratase |
Virmugen |
Aro-deleted S. Typhi
|
|
198
|
AroD |
Shigella flexneri 2a str. 2457T |
|
1078189
|
|
30063207
|
S1855 |
NC_004741.1 |
NP_837378.1 |
|
|
3-dehydroquinate dehydratase |
Virmugen |
S. flexneri strain Sfl 124
Shigella flexneri aroD mutant vaccine
|
|
4379
|
ARP2 |
Entamoeba histolytica |
|
|
|
AAF21857
|
|
|
|
|
CDD:100111 |
acidic ribosomal protein P2 |
Protective antigen |
|
|
367
|
asaP1 |
Aeromonas salmonicida subsp. salmonicida A449 |
VO_0011025
|
23570045
|
|
AAN63381
|
ASA_RS08320 |
|
|
|
CDD:296129
CDD:199915 |
toxic extracellular endopeptidase |
Protective antigen |
|
|
956
|
asd |
Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S |
|
|
|
267995764
|
|
|
|
|
CDD:180636
CDD:189205
CDD:145758 |
aspartate-semialdehyde dehydrogenase |
Virmugen |
Salmonella Typhimurium asd mutant vaccine
Salmonella Typhimurium asd/rfc mutant vaccine
|
|
1090
|
asd |
Burkholderia pseudomallei 1026b |
|
|
|
2358232
|
|
|
|
|
CDD:200773
CDD:162144 |
aspartate beta-semialdehyde dehydrogenase |
Virmugen |
Burkholderia pseudomallei asd mutant vaccine
|
|
1103
|
AsnC |
Brucella abortus 2308 |
|
3788213
|
|
489054600
|
BAB_RS24000 |
JMRZ01000003 |
WP_002964767 |
|
|
ArsR family transcriptional regulator |
Protective antigen |
Recombinant B. abortus AsnC protein with CFA/IFA adjuvant
|
|
1605
|
ASP-2 |
Trypanosoma cruzi strain Brazil |
|
|
1684906
|
1684907
|
|
|
AAC47720.1 |
|
CDD:240366
CDD:271234 |
amastigote surface protein-2 |
Protective antigen |
|
|
1607
|
ASP-2 from strain Tulahuen |
Trypanosoma cruzi strain Tulahuen |
|
|
284180152
|
284180153
|
|
|
ADB82626.1 |
|
CDD:240366
CDD:271234 |
amastigote surface protein-2 |
Protective antigen |
|
|
1606
|
ASP-2 from the Y strain |
Trypanosoma cruzi strain Y |
|
|
|
30313709
|
|
|
|
|
CDD:240366
CDD:271234
CDD:304605 |
surface protein-2 |
Protective antigen |
|
|
1604
|
ASP1 |
Trypanosoma cruzi strain Sylvio X-10/4 |
|
|
1658194
|
1658195
|
|
|
AAB18265.1 |
|
CDD:271234
CDD:304605 |
surface protein-1 |
Protective antigen |
T. cruzi DNA vaccine encoding TSA-1, ASP-1, ASP-2
|
|
997
|
asp24 |
|
|
|
2352999
|
2353000
|
|
|
AAB69346.1 |
|
CDD:151121 |
acid shock protein |
Virmugen |
B. abortus and B. melitensis mutants with unmarked deletion of asp24, virB2, or manBA
|
|
4735
|
ASTE1 |
Homo sapiens |
|
28990
|
|
572881924
|
|
AC055733 |
NP_001275879 |
|
|
transcript variant 3 |
Protective antigen |
AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
|
|
4665
|
ATL1 |
Homo sapiens |
|
51062
|
|
189181742
|
|
AL118556 |
NP_001121185 |
|
|
transcript variant 3 |
Protective antigen |
|
|
1020
|
atpA |
Salmonella enterica subsp. enterica serovar Typhimurium SL1344 |
|
|
|
301160399
|
STM3867 |
AE006468 |
NP_462766 |
|
CDD:181753
CDD:199133
CDD:29998
CDD:144044
UniProtKB/TrEMBL: E1WDU3 |
ATP synthase alpha subunit |
Virmugen |
Salmonella Typhimurium atpA mutant vaccine
|
|
4049
|
atpA |
Chlamydia muridarum str. Nigg |
|
|
|
AAF39416
|
|
|
|
|
CDD:235248 |
ATP synthase, subunit A |
Protective antigen |
|
|
114
|
B. abortus strain 19 L7/L12 |
Strain 19 |
VO_0010928
|
|
|
304271
|
|
L19101 |
|
|
CDD:234671
CDD:100102 |
ribosomal protein L7/L12 |
Protective antigen |
B. abortus subunit vaccine using L7/L12
B. abortus DNA vaccine expressing BCSP31, SOD and L7/L12
B. abortus DNA vaccine pcDNA3.1-p39-L7/L12 encoding p39-L7/L12 fusion protein
|
|
110
|
B. melitensis M5 P39 |
B. melitensis strain M5 |
VO_0010948
|
|
|
122892474
|
|
EF189139 |
ABM67295 |
|
CDD:224567
CDD:304360 |
immunogenic 39-kDa protein |
Protective antigen |
B. melitensis P39 protein vaccine
|
|
4546
|
B4GALNT1 |
Homo sapiens |
|
2583
|
|
451172101
|
|
AC025165 |
NP_001263397 |
|
|
transcript variant X4 |
Protective antigen |
Monoclonal Antibody A1G4 Anti-Idiotype Vaccine
|
|
1402
|
B5R |
Vaccinia virus |
|
3707658
|
|
66275984
|
VACWR187 |
A22016 |
YP_233069 |
|
|
EEV membrane glycoprotein |
Protective antigen |
Vaccinia virus DNA vaccine B5R
|
|
1623
|
B5R |
Vaccinia virus strain IHD-J |
|
|
|
63002626
|
|
|
|
|
CDD:165263
CDD:200988
CDD:153056 |
EEV type-I membrane glycoprotein |
Other |
|
|
1627
|
B5R |
Vaccinia virus strain Connaught |
|
|
|
29029576
|
|
|
|
|
CDD:165263
CDD:278512
CDD:153056 |
B5R |
Protective antigen |
Vaccinia virus DNA vaccine 4pox
|
|
31
|
B5R from Monkeypox virus (strain: Zaire-96-I-16) |
Monkeypox virus (strain: Zaire-96-I-16) |
|
928916
|
|
|
MPXVgp166 |
|
|
|
|
|
|
Smallpox DNA Vaccine
|
|
55
|
B5R from Vaccinia virus (strain: WR (Western Reserve)) |
Vaccinia virus (strain: WR (Western Reserve)) |
|
3707658
|
|
|
VACWR187 |
|
|
|
|
|
|
LC16m8
IMV-EEV
|
|
1644
|
BAB1_0278 |
Brucella melitensis biovar Abortus 2308 |
|
|
|
82615279
|
|
|
|
|
CDD:264424
EnsemblGenomes-Gn:BAB1_0278
EnsemblGenomes-Tr:CAJ10234
InterPro: IPR011681
UniProtKB/TrEMBL: Q2YPC5 |
conserved hypothetical protein |
Protective antigen |
B. abortus DNA vaccine pVF278
|
|
4223
|
bac |
Streptococcus agalactiae |
|
|
|
BAC98831
|
|
|
|
|
CDD:273479
CDD:301352
CDD:214653
CDD:285864
CDD:293433
CDD:282865
CDD:283799
CDD:279132 |
c protein beta antigen |
Protective antigen |
|
|
1317
|
BAX |
Homo sapiens |
|
581
|
|
612149787
|
|
AB183034 |
NP_001278357 |
|
|
transcript variant X1 |
Protective antigen |
Autoimmune diabetes DNA vaccine pND2-GAD65-BAX encoding GAD and BAX
|
|
4457
|
BCAP31 |
Homo sapiens |
|
10134
|
|
213511012
|
|
CH471172 |
NP_001132913 |
|
|
transcript variant X2 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
|
|
4671
|
BCL2L1 |
Homo sapiens |
|
598
|
|
4502381
|
|
AL117381 |
NP_001182 |
|
|
transcript variant 6 |
Protective antigen |
Bcl-Xs Adenovirus Vaccine
|
|
1676
|
BCSP31 |
Brucella abortus |
|
|
144104
|
144105
|
|
|
AAA22993.1 |
|
CDD:273982 |
cell surface protein |
Protective antigen |
B. abortus DNA vaccine expressing BCSP31, SOD and L7/L12
|
|
1299
|
bcsp31 from Brucella |
Brucella |
|
|
|
361049819
|
|
|
|
|
CDD:32505
CDD:212369 |
TRAP transporter solute receptor, TAXI family precursor |
Other |
|
|
565
|
Beta-tubulin |
Leishmania donovani |
VO_0011155
|
|
|
262233287
|
|
|
|
|
CDD:276956
CDD:240228 |
beta tubulin |
Protective antigen |
L. donovani Beta-tubulin Protein Vaccine
|
|
681
|
Bfr from B. abortus S19 |
Brucella abortus S19 |
VO_0010907
|
6326162
|
|
189022832
|
BAbS19_II06320 |
CP000888 |
YP_001932573 |
|
|
Bacterioferritin |
Protective antigen |
|
|
255
|
Bfr from B. melitensis biovar Abortus 2308 |
Brucella abortus 2308 |
VO_0010968
|
3828133
|
|
489055925
|
BAB_RS29555 |
JMRZ01000012 |
WP_002966069 |
3FVB
|
|
bacterioferritin |
Protective antigen |
|
|
1829
|
bfrA |
Mycobacterium tuberculosis H37Rv |
|
885767
|
|
15609013
|
Rv1876 |
AL123456 |
NP_216392 |
|
|
bacterioferritin BfrA |
Protective antigen |
BCG-DHTM
|
|
4224
|
bibA |
Streptococcus agalactiae |
|
|
|
AHJ88300
|
|
|
|
|
|
BibA |
Protective antigen |
|
|
627
|
binding protein Eag |
Streptococcus equi subsp. equi 4047 |
VO_0011211
|
7696154
|
|
225870123
|
SEQ_0721 |
FM204883 |
YP_002746070 |
|
CDD:144825 |
Ig, alpha2-macroglobulin and albumin binding protein Eag |
Protective antigen |
S. equi Subunit EAG, FNZ and SFS Protein Vaccine
|
|
4351
|
BiP |
Toxoplasma gondii |
|
|
|
AAF23321
|
|
|
|
|
CDD:331774 |
heat shock protein 70 precursor |
Protective antigen |
|
|
869
|
BipA |
Streptococcus agalactiae |
|
|
|
255961211
|
|
|
|
|
CDD:310807
CDD:114603
CDD:307064 |
BibA |
Protective antigen |
S. agalactiae BipA Protein Vaccine
|
|
4072
|
bipB |
Burkholderia pseudomallei |
|
|
|
ABO26356
|
|
|
|
|
CDD:332605 |
BipB |
Protective antigen |
|
|
4068
|
BipD |
Burkholderia pseudomallei |
|
|
|
ABL67521
|
|
|
|
|
CDD:297251 |
BipD |
Protective antigen |
|
|
4081
|
BmpA |
Borrelia burgdorferi N40 |
|
|
|
AAG00584
|
|
|
|
|
CDD:280728
CDD:107349 |
BmpA |
Protective antigen |
|
|
4082
|
BmpB |
Borrelia burgdorferi N40 |
|
|
|
AAG00585
|
|
|
|
|
CDD:299141 |
BmpB |
Protective antigen |
|
|
4083
|
BmpD |
Borrelia burgdorferi N40 |
|
|
|
AAG00582
|
|
|
|
|
CDD:280728
CDD:107349 |
BmpD |
Protective antigen |
|
|
4229
|
bont |
Clostridium botulinum |
|
|
|
AII82280
|
|
|
|
|
CDD:307728
CDD:311759
CDD:311760
CDD:285226 |
botulinum neurotoxin type E variant E1 |
Protective antigen |
|
|
445
|
BoNT/A1 from C. botulinum |
|
VO_0010900
|
|
|
241183337
|
|
|
|
3NF3
|
CDD:307728
CDD:311759
CDD:311760
CDD:285226 |
Bont/A1 |
Protective antigen |
|
|
448
|
BoNT/A1 from C. botulinum A str. Hall |
Clostridium botulinum A str. Hall |
VO_0010903
|
5398487
|
|
153936924
|
CLC_0862 |
CP000727 |
YP_001386738 |
3NF3
|
|
botulinum neurotoxin type A1 |
Protective antigen |
C. botulinum DNA vaccine pSCARSA/BHc
|
|
449
|
BoNT/B |
Clostridium botulinum B1 str. Okra |
VO_0010904
|
6030102
|
|
169834607
|
CLD_A0068 |
AB232927 |
YP_001693307 |
1S0F
|
CDD:279999
CDD:285227
CDD:285228
CDD:285226 |
botulinum neurotoxin type B |
Protective antigen |
C. botulinum DNA vaccine pSCARSBHc
C. botulinum DNA vaccine pSCARSA/BHc
|
|
450
|
BoNT/C(Hc50) |
|
VO_0010905
|
|
|
217781
|
|
|
BAA14235.1 |
|
CDD:307728
CDD:311759
CDD:328935
CDD:285226 |
botulinum C1 neurotoxin |
Protective antigen |
|
|
4232
|
BoNT/D |
Clostridium botulinum |
|
|
|
BAE53579
|
|
|
|
|
|
botulinum neurotoxin type D precursor |
Protective antigen |
|
|
4069
|
bopE |
Burkholderia pseudomallei |
|
|
|
CRY24974
|
|
|
|
|
|
type III secretion target BopE |
Protective antigen |
|
|
4077
|
Borrelia Burgdorferi Outer Surface Lipoprotein Bba64 |
Borrelia burgdorferi |
|
|
|
4ALY_B
|
|
|
|
|
CDD:283392 |
Borrelia Burgdorferi Outer Surface Lipoprotein Bba64 |
Protective antigen |
|
|
447
|
botA |
|
VO_0010902
|
|
|
733429
|
|
|
|
|
CDD:285228
CDD:285226 |
botulinum neurotoxin serotype A Hc fragment |
Protective antigen |
|
|
4352
|
bov57 |
Babesia bovis |
|
|
|
BBA45742
|
|
|
|
|
|
BOV57 |
Protective antigen |
|
|
232
|
Bp26 |
Brucella melitensis bv. 1 str. 16M |
VO_0010962
|
1196247
|
|
17986819
|
BMEI0536 |
AE008917 |
NP_539453 |
|
|
immunogenic protein |
Protective antigen |
|
|
1053
|
bp26 |
Brucella melitensis bv. 1 str. Rev.1 |
|
|
|
265991532
|
|
|
|
|
CDD:194028 |
outer membrane protein Bp26 |
Virmugen |
Brucella melitensis bp26 mutant vaccine
|
|
4214
|
Branched-chain alpha-keto acid dehydrogenase subunit E2 |
Streptococcus agalactiae |
|
|
|
AFV72219
|
|
|
|
|
CDD:237001
CDD:308457 |
Branched-chain alpha-keto acid dehydrogenase subunit E2 |
Protective antigen |
|
|
383
|
brkA |
Bordetella pertussis |
VO_0011036
|
|
|
562026
|
|
|
|
|
CDD:332715
CDD:238653
CDD:273608 |
BrkA |
Protective antigen |
B. pertussis BrkA protein vaccine
|
|
1066
|
bscN |
Bordetella bronchiseptica RB50 |
|
2662485
|
|
33600613
|
BB1628 |
BX640441 |
NP_888173 |
|
|
type III secretion system ATPase |
Virmugen |
Bordetella bronchiseptica bscN and cyaA double mutant vaccine
|
|
570
|
BT1 |
Leishmania donovani |
VO_0011160
|
|
|
703123
|
|
|
|
|
CDD:273268
CDD:281135 |
unknown |
Protective antigen |
|
|
924
|
C protein |
Tick-borne encephalitis virus |
|
|
|
206570298
|
|
|
|
|
CDD:110034 |
capsid protein |
Virmugen |
Tick-borne Encephalitis Virus C protein mutant vaccine
|
|
925
|
C protein |
West Nile virus |
|
|
|
158516889
|
|
|
|
|
CDD:144552
VBRC:36387 |
capsid protein |
Virmugen |
West Nile virus C protein mutant vaccine
|
|
4243
|
C protein |
Eastern Equine Encephalitis Virus |
|
|
|
NP_740644
|
|
|
|
|
CDD:279312 |
C protein |
Protective antigen |
|
|
4222
|
C protein alpha-antigen |
Streptococcus agalactiae |
|
|
|
AIF88081
|
|
|
|
|
CDD:273479
CDD:204077
CDD:298076
CDD:279132 |
C protein alpha-antigen |
Protective antigen |
|
|
1736
|
C-E3-E2-E1-6K |
Venezuelan equine encephalitis virus (strain TC-83) |
|
|
|
130559
|
|
|
|
|
CDD:279312
CDD:279849
CDD:279311
CDD:279870 |
Structural polyprotein |
Protective antigen |
VEE virus DNA vaccine pSTU-TRDF encoding VEEV E3–E2–6K
|
|
283
|
C0393 |
Escherichia coli CFT073 |
VO_0010989
|
1034958
|
|
26246291
|
c0393 |
AE014075 |
NP_752330 |
|
|
hemoglobin protease |
Protective antigen |
E. coli vaccine based on recombinant protein CO393
|
|
4230
|
c2I |
Clostridium botulinum |
|
|
|
ADD91305
|
|
|
|
|
CDD:238144 |
C2I |
Protective antigen |
|
|
4231
|
c2II |
Clostridium botulinum |
|
|
|
ADD91306
|
|
|
|
|
CDD:214807
CDD:281492 |
C2II |
Protective antigen |
|
|
284
|
C4424 |
Escherichia coli CFT073 |
VO_0010990
|
1038067
|
|
26250246
|
c4424 |
AE014075 |
NP_756286 |
|
|
adhesin |
Protective antigen |
E. coli C4424 protein vaccine
|
|
4550
|
CA9 |
Homo sapiens |
|
768
|
|
169636420
|
|
AL133410 |
NP_001207 |
|
|
transcript variant X2 |
Protective antigen |
mRNA-electroporated dendritic cells encoding gp100 and tyrosinase as melanoma vaccine
|
|
419
|
CAB049 putative penicillin-binding protein |
Chlamydophila abortus |
VO_0011059
|
|
|
62184696
|
|
|
|
|
CDD:332066 |
penicillin-binding protein |
Protective antigen |
C. abortus DNA vaccine encoding CAB049
|
|
421
|
CAB613 putative peptidase |
Chlamydophila abortus |
VO_0011061
|
|
|
62185225
|
|
|
|
|
CDD:189015 |
peptidase |
Protective antigen |
C. abortus DNA vaccine encoding CAB613
|
|
396
|
cadF |
Campylobacter jejuni |
VO_0011044
|
|
|
WP_002851185
|
|
|
|
|
CDD:275358
CDD:225439
CDD:143586 |
fibronectin-binding outer membrane protein CadF |
Protective antigen |
C. jejuni DNA vaccine pcDNA3.1(+)-cadF
|
|
355
|
caf1 |
Yersinia pestis |
VO_0011017
|
|
|
48621
|
|
|
|
|
CDD:286355
GOA:P26948
InterPro: IPR008966
InterPro: IPR015335
PDB: 1P5U
PDB: 1P5V
PDB: 1Z9S
PDB: 3DOS
PDB: 3DPB
PDB: 3DSN
UniProtKB/UniProt: P26948 |
F1 capsule antigen |
Protective antigen |
Y. pestis DNA vaccine encoding dfF1 Protein
|
|
23
|
Caf1 from Y. pestis biovar Microtus str. 91001 |
Yersinia pestis biovar Microtus str. 91001 |
VO_0010870
|
2767670
|
|
45478667
|
YP_pMT082 |
AE017045 |
NP_995523 |
|
|
F1 capsule antigen |
Protective antigen |
Y. pestis F1 protein vaccine
Y. pestis DNA vaccine F1-V DNA
|
|
3922
|
cagA |
Helicobacter pylori |
|
|
|
WP_130778457
|
|
|
|
|
CDD:302624 |
type IV secretion system oncogenic effector CagA |
Protective antigen |
Epivac vaccine
|
|
3917
|
cagL |
Helicobacter pylori |
|
|
|
APP94146
|
|
|
|
|
|
cag pathogenicity island protein CagL |
Protective antigen |
|
|
1734
|
calpain |
Schistosoma mansoni strain Puerto Rico |
|
|
|
353230291
|
|
|
|
|
CDD:279042
CDD:238004
CDD:279416
CDD:238132
CDD:290234
CDD:238008 |
calpain (C02 family) |
Protective antigen |
S. mansoni DNA vaccine Sm-p80-pcDNA3 encoding the large subunit of S. mansoni calpain
|
|
4281
|
cap |
Porcine circovirus 2 |
|
|
|
AAF35305
|
|
|
|
|
CDD:280582 |
putative capsid protein |
Protective antigen |
|
|
933
|
capB |
Francisella tularensis subsp. holarctica LVS |
|
3952402
|
|
89256709
|
FTL_1416 |
AM233362 |
YP_514071 |
|
|
capsule biosynthesis protein capB |
Virmugen |
Francisella tularensis capB mutant vaccine
|
|
3963
|
capB |
Francisella tularensis |
|
|
|
ABD95977
|
|
|
|
|
CDD:188527 |
CapB |
Protective antigen |
|
|
1327
|
capsule biosynthesis protein |
Bacillus anthracis |
|
|
|
WP_000409765
|
|
|
|
|
CDD:311953
CDD:332959
CDD:282847
CDD:99910 |
capsule synthesis positive regulator AcpB |
Other |
|
|
953
|
carA |
Escherichia coli str. K-12 substr. MG1655 |
|
949025
|
|
16128026
|
b0032 |
U00096 |
NP_414573 |
1Q15
|
|
carbamoyl phosphate synthetase small subunit, glutamine amidotransferase |
Virmugen |
Escherichia coli carAB mutant vaccine
|
|
954
|
carB |
Escherichia coli str. K-12 substr. MG1655 |
|
944775
|
|
16128027
|
b0033 |
U00096 |
NP_414574 |
2A81
|
|
carbamoyl-phosphate synthase large subunit |
Virmugen |
Escherichia coli carAB mutant vaccine
|
|
4382
|
cathepsin B1 (SmCB1) |
Schistosoma mansoni |
|
|
|
4I07_A
|
|
|
|
|
CDD:239111 |
cathepsin B1 (SmCB1) |
Protective antigen |
|
|
4388
|
cathepsin B2 |
Trichinella spiralis |
|
|
|
ARG41449
|
|
|
|
|
CDD:312252
CDD:239111 |
cathepsin B2 |
Protective antigen |
|
|
972
|
cbiA |
Salmonella enterica subsp. enterica serovar Gallinarum str. 287/91 |
|
6923268
|
|
205353181
|
SG2061 |
AM933173 |
YP_002226982 |
|
|
cobyrinic acid a,c-diamide synthase |
Virmugen |
Salmonella Gallinarum cbiA/cobS mutant vaccine
|
|
619
|
CbpA |
Streptococcus pneumoniae D39 |
VO_0011203
|
4441159
|
|
116515359
|
SPD_2017 |
CP000410 |
YP_817402 |
1W9R
|
|
choline binding protein A |
Protective antigen |
S. pneumoniae CbpA Protein Vaccine
|
|
4691
|
CCL21 |
Homo sapiens |
|
6366
|
|
4506835
|
|
AF030572 |
NP_002980 |
|
|
C-C motif chemokine ligand 21 |
Protective antigen |
Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
|
|
1390
|
Ccl21a |
Mus musculus |
|
18829
|
|
14547891
|
RP23-411B7.4 |
AF035684 |
NP_035254 |
|
|
chemokine (C-C motif) ligand 21A (serine) |
Protective antigen |
|
|
4495
|
CCNI |
Homo sapiens |
|
10983
|
|
1130413436
|
|
AC104771 |
NP_001335061 |
|
|
transcript variant 1 |
Protective antigen |
IMT-1012 Immunotherapeutic Vaccine
|
|
4540
|
CCR5 |
Homo sapiens |
|
1234
|
|
4502639
|
|
AB182982 |
NP_000570 |
|
|
transcript variant A |
Protective antigen |
Mesothelioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
|
|
4718
|
CCR7 |
Homo sapiens |
|
1236
|
|
683523912
|
|
AC004585 |
NP_001288643 |
|
|
transcript variant 2 |
Protective antigen |
|
|
4723
|
CD19 |
Homo sapiens |
|
930
|
|
296010921
|
|
AB052799 |
NP_001171569 |
|
|
transcript variant X3 |
Protective antigen |
|
|
4714
|
CD1D |
Homo sapiens |
|
912
|
|
982742445
|
|
AF142668 |
NP_001306074 |
|
|
transcript variant X3 |
Protective antigen |
|
|
4642
|
CD22 |
Homo sapiens |
|
933
|
|
297374825
|
|
AB012995 |
NP_001172028 |
|
|
transcript variant 4 |
Protective antigen |
EF-2 Peptide Vaccine
|
|
699
|
Cd276 |
Mus musculus |
|
102657
|
|
19527206
|
|
CH466522 |
NP_598744 |
|
|
CD276 antigen |
Protective antigen |
|
|
4319
|
CD2v |
African Swine Fever Virus |
|
|
|
AJB28435
|
|
|
|
|
|
CD2v |
Protective antigen |
|
|
4738
|
CD33 |
Homo sapiens |
|
945
|
|
130980072
|
|
AC063977 |
NP_001076087 |
|
|
transcript variant X2 |
Protective antigen |
Allogeneic AML Antigen-expressing Dendritic Cell Vaccine
|
|
4693
|
CD38 |
Homo sapiens |
|
952
|
|
38454326
|
|
AC005798 |
NP_001766 |
|
|
transcript variant 2 |
Protective antigen |
Autologous Dendritic Cell-Tumor Fusion Vaccine
|
|
4733
|
CD3D |
Homo sapiens |
|
915
|
|
4502669
|
|
AH002612 |
NP_000723 |
|
|
transcript variant 2 |
Protective antigen |
|
|
4446
|
CD40 |
Homo sapiens |
|
958
|
|
4507581
|
|
AL035662 |
NP_001241 |
|
|
transcript variant 7 |
Protective antigen |
Adenovirus 5-CD40 Ligand
Prostate Cancer Vaccine ONY-P1
Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003
Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101
Allogeneic Dendritic Cell-Myeloma Idiotype Vaccine
Autologous Dendritic Cell Vaccine ACT2001
Cancer DNA Vaccine pSURV encoding Survivin
|
|
305
|
Cd40lg |
Mus musculus |
|
21947
|
|
15011846
|
RP23-153G22.3 |
AH006031 |
NP_035746 |
|
|
CD40 ligand |
Protective antigen |
Cancer Retroviral Vector Vaccine encoding Cd40lg
|
|
4698
|
CD40LG |
Homo sapiens |
|
959
|
|
4557433
|
|
AB897731 |
NP_000065 |
|
|
CD40 ligand |
Protective antigen |
Ad-sig-hMUC-1/ecdCD40L Vaccine
Autologous Ad-CD154-Transduced CLL B Cells
Allogeneic Renal Cell Carcinoma Vaccine MGN1601
Autologous CD40L-expressing B-CLL Vaccine
Autologous TriMix-DC Melanoma Vaccine
|
|
4734
|
CD44 |
Homo sapiens |
|
960
|
|
48255935
|
|
AB462491 |
NP_000601 |
|
|
transcript variant X1 |
Protective antigen |
|
|
4542
|
CD55 |
Homo sapiens |
|
1604
|
|
10835143
|
|
AB003312 |
NP_000565 |
|
|
transcript variant 8 |
Protective antigen |
Monoclonal Antibody 105AD7 Anti-idiotype Vaccine
|
|
4613
|
CD58 |
Homo sapiens |
|
965
|
|
221316575
|
|
AL355794 |
NP_001138294 |
|
|
transcript variant 3 |
Protective antigen |
Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
Recombinant Fowlpox-TRICOM Vaccine
Rilimogene-galvacirepvec
ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
Brain Tumor Initiating Cell Vaccine
|
|
4748
|
CD70 |
Homo sapiens |
|
970
|
|
4507605
|
|
AC008760 |
NP_001243 |
|
|
transcript variant 2 |
Protective antigen |
Autologous TriMix-DC Melanoma Vaccine
|
|
311
|
Cd80 |
Mus musculus |
|
12519
|
|
1331037341
|
|
AC154425 |
NP_001346827 |
|
|
transcript variant X1 |
Protective antigen |
Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
Recombinant Fowlpox-TRICOM Vaccine
Recombinant Vaccinia-MUC1-B7 Vaccine
Rilimogene-galvacirepvec
Autologous IL-2-expressing B-CLL Vaccine
|
|
4702
|
CD80 |
Homo sapiens |
|
941
|
|
4885123
|
|
AB033124 |
NP_005182 |
|
|
CD80 molecule |
Protective antigen |
Adenovirus B7-1
Allogeneic Renal Cell Carcinoma Vaccine MGN1601
ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
ALVAC-B7-CEA
ALVAC-CEA (6D)-B7.1 Vaccine
Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine
CD80 Breast Cancer Vaccine
ALVAC-CEA B7.1 Vaccine
Brain Tumor Initiating Cell Vaccine
Newcastle disease virus lysate
Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
Recombinant Fowlpox-B7.1 Vaccine
|
|
304
|
Cd86 |
Mus musculus |
|
12524
|
|
161484599
|
|
AC117662 |
NP_062261 |
|
|
transcript variant X2 |
Protective antigen |
Cancer DNA Vaccine pLXSHDmB7-2 encoding Cd86
Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
|
|
693
|
Cd86 |
Rattus norvegicus |
|
56822
|
|
11464989
|
|
AABR07034349 |
NP_064466 |
|
|
transcript variant X1 |
Protective antigen |
|
|
1304
|
CD86 |
Homo sapiens |
|
942
|
|
332634950
|
|
AC068630 |
NP_001193853 |
|
|
transcript variant 1 |
Other |
Autologous IL-2-expressing B-CLL Vaccine
Autologous Tumor Cell Vaccine
|
|
4439
|
CD8A |
Homo sapiens |
|
925
|
|
225007536
|
|
AC064848 |
NP_001139345 |
|
|
transcript variant 4 |
Protective antigen |
Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine
|
|
4591
|
CD90 |
Homo sapiens |
|
7070
|
|
902967471
|
|
AP003396 |
NP_001298089 |
|
|
transcript variant 5 |
Protective antigen |
Allogeneic Glioblastoma Stem-like Cell Line Lysate-pulsed Autologous Dendritic Cell Vaccine
|
|
4759
|
CDH3 |
Homo sapiens |
|
1001
|
|
953953841
|
|
AC099314 |
NP_001304124 |
|
|
transcript variant X1 |
Protective antigen |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
|
|
4496
|
CDK1 |
Homo sapiens |
|
983
|
|
281427278
|
|
AC022390 |
NP_001163877 |
|
|
transcript variant 6 |
Protective antigen |
IMT-1012 Immunotherapeutic Vaccine
|
|
4471
|
cdsR |
Chlamydia trachomatis A/HAR-13 |
|
45091589
|
|
497557743
|
CTA_RS03050 |
CP000051 |
WP_009871927 |
|
|
SctR family type III secretion system export apparatus subunit CdsR |
Protective antigen |
Vaccinia Virus DD-CDSR
|
|
413
|
CDVgp5 |
Canine morbillivirus |
VO_0011053
|
1489793
|
|
9630650
|
CDVgp5 |
AF014953 |
NP_047205 |
|
|
fusion protein F |
Protective antigen |
Canine distemper virus DNA vaccine encoding F and HA
ALVAC- CDV-H/F
NYVAC- CDV-H/F
|
|
412
|
CDVgp6 haemagglutinin protein H |
Canine morbillivirus |
VO_0011052
|
1489792
|
|
9630651
|
CDVgp6 |
AB472690 |
NP_047206 |
|
|
haemagglutinin protein H |
Protective antigen |
Canine distemper virus DNA vaccine encoding F and HA
Canine distemper virus DNA vaccine encoding HA
NYVAC- CDV-H/F
ALVAC- CDV-H/F
|
|
4436
|
Cea-Mouse |
Mus musculus |
|
111518
|
|
|
|
|
|
|
|
carcinoembryonic antigen gene family |
Protective antigen |
Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine
|
|
4535
|
CEACAM1 |
Homo sapiens |
|
634
|
|
68161541
|
|
A43165 |
NP_001020083 |
|
|
transcript variant 5 |
Protective antigen |
Mammaglobin-A DNA Vaccine
Fowlpox Virus Vaccine
|
|
316
|
CEACAM3 |
Homo sapiens |
|
1084
|
|
461496471
|
|
AC022516 |
NP_001264092 |
|
|
transcript variant 3 |
Protective antigen |
|
|
1351
|
CEACAM5 (CEA) |
Homo sapiens |
|
1048
|
|
612407802
|
|
AC008999 |
NP_001278413 |
|
|
transcript variant 1 |
Protective antigen |
Cancer Subunit DC (Tat-CEA) vaccine
Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen
Monoclonal Antibody 3H1 Anti-Idiotype Vaccine
Adenoviral Vector Ad5-CEA(6D) Vaccine
Indium In 111-Labeled Autologous Peripheral Blood Mononuclear Cells Vaccine
Inalimarev Vaccine
Fowlpox Virus Vaccine Vector
Falimarev Vaccine
Algenpantucel-L
Anti-CEA TCR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes
ALVAC-CEA Vaccine
ALVAC-CEA (VCP248)
ALVAC-B7-CEA
ALVAC-CEA (6D)-B7.1 Vaccine
Allogeneic Cellular Vaccine 1650-G
Carcinoembryonic Antigen Peptide 1-6D
Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine
Carcinoembryonic Antigen Peptide-1 Vaccine
Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine
CEA RNA-pulsed Autologous Human Cultured Dendritic Cells
CEA/Tetanus Toxoid T Helper Epitope Fusion Protein-Expressing DNA Plasmid Vaccine
Dendritic Cell-CEA Peptide Vaccine
Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207
|
|
4568
|
CEACAM5 - obsolete |
Homo sapiens |
|
1048
|
|
612407802
|
|
AC008999 |
NP_001278413 |
|
|
transcript variant 1 |
Protective antigen |
EP-2101
Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
Recombinant Vaccinia-CEA
|
|
795
|
CEL-170/4 |
Entamoeba histolytica |
VO_0011326
|
|
|
401088
|
|
|
|
|
|
170 kDa surface lectin |
Protective antigen |
E. histolytica CEL-170/4 protein vaccine
|
|
4195
|
cell surface protein |
Streptococcus equi |
|
|
|
WP_043026814
|
|
|
|
|
CDD:303769
CDD:293650
CDD:302792
CDD:293879
CDD:295219
CDD:279132 |
cell surface protein |
Protective antigen |
|
|
923
|
cen1 |
|
|
|
|
15488542
|
|
|
|
|
CDD:185503
CDD:28933 |
centrin |
Virmugen |
Leishmania donovani cen1 mutant vaccine
|
|
3970
|
CFA/I |
Escherichia coli |
|
|
|
AAB22177
|
|
|
|
|
CDD:282325 |
colonization factor antigen I |
Protective antigen |
|
|
4342
|
Chain A, Eimeria Tenella Microneme Protein 3 Mar_b Domain |
Eimeria tenella |
|
|
|
2LBO_A
|
|
|
|
|
CDD:287526 |
Chain A, Eimeria Tenella Microneme Protein 3 Mar_b Domain |
Protective antigen |
|
|
4652
|
CHI3L1 |
Homo sapiens |
|
1116
|
|
144226251
|
|
AC105940 |
NP_001267 |
|
|
chitinase 3 like 1 |
Protective antigen |
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
|
|
133
|
cjaA |
Campylobacter jejuni RM1221 |
VO_0010955
|
3231573
|
|
1813949
|
CJE1064 |
CP000025 |
YP_179057 |
|
CDD:270412
GOA:P94643
InterPro: IPR001638
UniProtKB/TrEMBL: P94643 |
surface antigen, CjaA |
Protective antigen |
Avirulent Salmonella vaccine strain carrying C. jejuni cjaA gene
|
|
141
|
cjaA |
P. vivax SouthernMex-62 isolate |
VO_0010957
|
|
|
|
|
|
|
1Z27
|
CDD:270412
GOA:P94643
InterPro: IPR001638
UniProtKB/TrEMBL: P94643 |
|
Protective antigen |
P. vivax PVS25 with Montanide ISA-720
|
|
4777
|
CLEC3B |
Homo sapiens |
|
7123
|
|
817473757
|
|
AC104165 |
NP_001295323 |
|
|
transcript variant X1 |
Protective antigen |
Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine
|
|
4415
|
CLEC4C |
Homo sapiens |
|
170482
|
|
1701108502
|
|
AC006517 |
NP_001358319 |
|
|
transcript variant X3 |
Protective antigen |
Plasmacytoid Dendritic Cell Vaccine
|
|
847
|
ClfA |
Staphylococcus aureus subsp. aureus str. Newman |
VO_0012390
|
5330438
|
|
151220968
|
NWMN_0756 |
AP009351 |
YP_001331790 |
1N67
|
|
clumping factor A |
Protective antigen |
S. aureus ClfA Protein Vaccine
S. aureus DNA vaccine pClfaSrtD13
S. aureus DNA vaccine encoding Efb, FnbpA, ClfA, Cna
|
|
4183
|
clfB |
Staphylococcus aureus |
|
|
|
SIN33476
|
|
|
|
|
CDD:309682
CDD:313621
CDD:307064 |
Fibrinogen-binding protein B |
Protective antigen |
|
|
1004
|
clpB |
Francisella tularensis subsp. tularensis SCHU S4 |
|
3192509
|
|
56708764
|
FTT_1769c |
AJ749949 |
YP_170660 |
3P2L
|
|
ClpB protein |
Virmugen |
Francisella tularensis clpB mutant vaccine
|
|
608
|
ClpP |
Streptococcus pneumoniae D39 |
VO_0011193
|
4441476
|
|
WP_000613477
|
SPD_0650 |
CP000410 |
YP_816144 |
1Y7O
|
CDD:178955
CDD:132928 |
ATP-dependent Clp protease proteolytic subunit |
Protective antigen |
S. pneumoniae ClpP protein Vaccine
|
|
1089
|
clpP |
Salmonella enterica subsp. enterica serovar Enteritidis str. P125109 |
|
6950532
|
|
207855928
|
SEN0430 |
AM933172 |
YP_002242579 |
|
|
ATP-dependent Clp protease proteolytic subunit |
Virmugen |
Salmonella Enteritidis guaBA/clpP mutant vaccine
|
|
1003
|
clpP from S. typhimurium str. LT2 |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1251968
|
|
16763829
|
STM0448 |
AE006468 |
NP_459444 |
|
|
ATP-dependent Clp protease proteolytic subunit |
Virmugen |
Salmonella Typhimurium clpP mutant vaccine
Salmonella Typhimurium guaBA/clpP mutant vaccine
Salmonella Typhimurium guaBA/clpP/fliD mutant vaccine
|
|
846
|
cna |
Staphylococcus aureus |
VO_0012389
|
|
387879
|
WP_001039420
|
|
|
AAA20874.1 |
2F68
|
CDD:283410
CDD:283411
CDD:301706
CDD:212461 |
Cna B-type domain-containing protein |
Protective antigen |
S. aureus CNA Protein Vaccine
S. aureus DNA vaccine encoding Efb, FnbpA, ClfA, Cna
|
|
1102
|
cobB |
Brucella abortus 2308 |
|
3787893
|
|
489054238
|
BAB_RS22225 |
JMRZ01000005 |
WP_002964414 |
|
|
hydrogenobyrinate a,c-diamide synthase |
Protective antigen |
Recombinant B. abortus CobB protein with CFA/IFA adjuvant
|
|
971
|
cobS |
Salmonella enterica subsp. enterica serovar Gallinarum str. 287/91 |
|
6923296
|
|
205353166
|
SG2041 |
AM933173 |
YP_002226967 |
|
|
cobalamin synthase |
Virmugen |
Salmonella Gallinarum cbiA/cobS mutant vaccine
|
|
4360
|
cofactor-independent phosphoglycerate mutase |
Leishmania donovani |
|
|
|
ADG96010
|
|
|
|
|
CDD:215295
CDD:293734 |
cofactor-independent phosphoglycerate mutase |
Protective antigen |
|
|
1613
|
COL2A1 |
Gallus gallus |
|
|
15546069
|
15546070
|
|
|
AAK98621.1 |
|
CDD:189968
CDD:279718 |
alpha 1 type IIA collagen precursor |
Protective antigen |
|
|
629
|
collagen binding, ancillary pilus subunit Cne |
Streptococcus equi subsp. equi 4047 |
VO_0011213
|
7695900
|
|
225870316
|
SEQ_0935 |
FM204883 |
YP_002746263 |
|
CDD:283410
CDD:212461
CDD:273478 |
collagen binding, ancillary pilus subunit Cne |
Protective antigen |
S. equi Subunit CNE Protein Vaccine
|
|
1321
|
Collagen type II |
Gallus gallus |
|
395069
|
|
45383309
|
|
AADN05000742 |
NP_989757 |
|
|
transcript variant X1 |
Protective antigen |
Adjuvant arthritis DNA vaccine pcDNA-CCOL2A1 encoding type II collagen
|
|
1674
|
Collagen type II |
Mus musculus |
|
12824
|
|
169658375
|
|
AC113444 |
NP_001106987 |
|
|
transcript variant 2 |
Protective antigen |
Adjuvant arthritis DNA vaccine CII encoding type II collagen
|
|
4017
|
com1 |
Coxiella burnetii |
|
|
|
AAG41990
|
|
|
|
|
CDD:224565
CDD:239321 |
27kDa outer membrane protein |
Protective antigen |
|
|
4055
|
COMC |
Chlamydia trachomatis |
|
|
|
CRH78535
|
|
|
|
|
|
COMC family |
Protective antigen |
|
|
1228
|
Complete genome |
Murine leukemia virus |
|
|
378404894
|
53749063
|
|
|
BAD52415.1 |
|
|
GAG polyprotein precursor |
Other |
|
|
429
|
copN |
Chlamydophila pneumoniae |
VO_0010884
|
|
|
33241669
|
|
|
|
|
CDD:274206 |
CopN |
Protective antigen |
C. pneumoniae CopN protein vaccine
|
|
1267
|
Core protein |
Simian immunodeficiency virus |
|
|
|
54312018
|
|
|
|
|
CDD:109591
CDD:201337
CDD:199156 |
core protein |
Other |
SIV DNA vaccine pSIVgag and pmacIL-15 encoding SIV core protein
|
|
1289
|
Core protein |
Hepatitis C virus |
|
|
|
349623451
|
|
|
|
|
CDD:144947 |
core |
Other |
|
|
758
|
CP cysteine proteinase |
Leishmania amazonensis |
VO_0011295
|
|
30142041
|
30142042
|
|
|
AAN34826.1 |
|
CDD:185513
CDD:214853
CDD:278538
CDD:239068 |
cysteine proteinase |
Protective antigen |
L. amazonensis CP Protein Vaccine
|
|
4386
|
CP1412 |
Schistosoma japonicum |
|
|
|
AAS68246
|
|
|
|
|
CDD:238512 |
egg protein CP1412 |
Protective antigen |
|
|
777
|
CP15/60 |
Cryptosporidium parvum |
VO_0011309
|
|
170676501
|
170676502
|
|
|
ACB30404.1 |
|
|
sporozoite surface antigen CP15/60 |
Protective antigen |
C. parvum DNA vaccine encoding CP15/60
|
|
4378
|
CP15/60 |
Cryptosporidium parvum |
|
|
|
AAA28294
|
|
|
|
|
|
CP15/60 |
Protective antigen |
|
|
4315
|
CP204L |
African Swine Fever Virus |
|
|
|
AGL93215
|
|
|
|
|
|
p32 |
Protective antigen |
|
|
4318
|
CP204L |
African Swine Fever Virus |
|
|
|
AHN94305
|
|
|
|
|
|
p30 |
Protective antigen |
|
|
776
|
CP23 |
Cryptosporidium parvum |
VO_0011308
|
|
|
88659549
|
|
|
|
|
|
Cp23 antigen |
Protective antigen |
C. parvum DNA vaccine encoding CP23
|
|
1301
|
cp24 from Brucella melitensis |
Brucella melitensis |
|
|
|
1674445
|
|
|
|
|
CDD:178850
CDD:29621 |
CP24 |
Other |
|
|
4380
|
CP3 |
Entamoeba histolytica |
|
|
|
CAA60673
|
|
|
|
|
CDD:214853
CDD:278538
CDD:239068
GOA:P36184
InterPro: IPR000169
InterPro: IPR000668
InterPro: IPR013128
InterPro: IPR013201
UniProtKB/UniProt: P36184 |
cysteine proteinase |
Protective antigen |
|
|
4317
|
CP530R |
African Swine Fever Virus |
|
|
|
AHN94308
|
|
|
|
|
CDD:295006 |
pp62 |
Protective antigen |
|
|
737
|
Cpa |
Leishmania major |
VO_0011275
|
|
71084305
|
71084306
|
|
|
AAZ23598.1 |
|
CDD:185513
CDD:285458
CDD:278538
CDD:239068 |
cysteine protease |
Protective antigen |
L. major DNA Vaccine encoding LACKp24, TSA, LmSTI1 and CPa
|
|
4043
|
CPAF |
Chlamydia trachomatis |
|
|
|
WP_009873463
|
|
|
|
|
CDD:321971
CDD:214582 |
protease-like activity factor CPAF |
Protective antigen |
|
|
744
|
cpb |
Leishmania major |
VO_0011281
|
|
|
54287314
|
|
|
|
|
CDD:278538
CDD:239068
GOA:Q5ZQK2
InterPro: IPR000169
InterPro: IPR000668
InterPro: IPR013128
UniProtKB/TrEMBL: Q5ZQK2 |
cysteine proteinase b |
Protective antigen |
|
|
382
|
cpn60 |
Bordetella pertussis |
VO_0011035
|
|
|
968920
|
|
|
|
|
CDD:234573
CDD:239460 |
Cpn60 (GroEL) |
Protective antigen |
B. pertussis Cpn60 protein vaccine
|
|
4844
|
CpP2 |
Cryptosporidium parvum |
|
|
|
AAF21857.1
|
|
|
|
|
CDD:100111 |
acidic ribosomal protein P2 |
Protective antigen |
C. parvum DNA vaccine encoding CpP2
|
|
892
|
cps |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1035
|
cpxA |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1255585
|
|
16767324
|
STM4058 |
AE006468 |
NP_462939 |
|
|
two-component sensor protein |
Virmugen |
Salmonella Typhimurium gyrA/cpxA/rpoB mutant vaccine
|
|
4096
|
cpxD |
Actinobacillus pleuropneumoniae serovar 2 str. S1536 |
|
|
|
AAB64442
|
|
|
|
|
CDD:132072
CDD:280687 |
CpxD |
Protective antigen |
|
|
959
|
cpxR |
Salmonella enterica subsp. enterica serovar Gallinarum str. 287/91 |
|
6923307
|
|
205354363
|
SG3362 |
AM933173 |
YP_002228164 |
|
|
DNA-binding transcriptional regulator CpxR |
Virmugen |
Salmonella Gallinarum cpxR/Ion mutant vaccine
|
|
958
|
crp |
Salmonella enterica subsp. enterica serovar Gallinarum |
|
|
46811320
|
46811321
|
|
|
AAT01929.1 |
|
|
cAMP receptor protein |
Virmugen |
Salmonella Gallinarum crp mutant vaccine
|
|
327
|
crp |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1099
|
crp |
Edwardsiella ictaluri 93-146 |
|
7962173
|
|
238921513
|
NT01EI_3665 |
CP001600 |
YP_002935028 |
|
|
cAMP-regulatory protein |
Virmugen |
E. ictaluri crp mutant vaccine
|
|
1101
|
crp from S. Typhimurium |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1254989
|
|
16766754
|
STM3466 |
AE006468 |
NP_462369 |
|
|
cAMP-regulatory protein |
Virmugen |
Salmonella Typhimurium cya/crp mutant vaccine
|
|
760
|
CRP-10 |
|
VO_0011297
|
|
|
1389837
|
|
|
|
|
CDD:271234
CDD:290570 |
complement regulatory protein |
Protective antigen |
T. cruzi DNA Vaccine encoding CRP-10 Protein
|
|
1386
|
CRTC |
Homo sapiens |
|
|
|
1905911
|
|
|
|
|
CDD:306718 |
calreticulin |
Protective antigen |
Human papillomavirus DNA vaccine hCRTE6E7L2 DNA encoding CRT linked to E6, E7 and L2
|
|
756
|
Cruzipain |
Trypanosoma cruzi |
VO_0011293
|
|
|
1136308
|
|
|
|
|
CDD:185513
CDD:214853
CDD:278538
CDD:239068
CDD:288946 |
cruzipain |
Protective antigen |
T. cruzi vaccine using attenuated Salmonella expressing T. cruzi Cruzipain
|
|
4656
|
CRY2 |
Arabidopsis thaliana |
|
839529
|
|
15219720
|
AT1G04400 |
CP002684 |
NP_171935 |
|
|
|
Protective antigen |
|
|
633
|
CS from P. berghei str. ANKA |
Plasmodium berghei ANKA |
VO_0011217
|
3428738
|
|
1269284025
|
PBANKA_040320 |
LK023119 |
XP_022712148 |
|
|
|
Protective antigen |
Plasmodium berghei CS Protein Subunit Vaccine
P. berghei DNA vaccine encoding PbCSP
P. berghei DNA vaccine CSP-3p28
|
|
634
|
CS from P. falciparum |
Plasmodium falciparum |
VO_0011218
|
|
|
552191
|
|
|
|
|
CDD:278517 |
circumsporozoite protein |
Protective antigen |
P. falciparum CS expressed in irradiated P. berghei as Vaccine
RTS,S/AS01
|
|
635
|
CS from P. yoelii str. 17XNL |
Plasmodium yoelii yoelii 17XNL |
VO_0011219
|
3830374
|
|
83317409
|
PY03168 |
AABL01000897 |
XP_731149 |
|
|
|
Protective antigen |
P. yoelii DNA vaccine pDIP/PyCSP. 1
|
|
79
|
CS1 |
Escherichia coli 536 |
VO_0010941
|
4188469
|
|
110643341
|
ECP_3188 |
CP000247 |
YP_671071 |
|
|
CS1 type fimbrial major subunit |
Protective antigen |
Live attenuated ETEC vaccine ACAM2017
EHEC O157 subunit vaccine using his-tagged N-terminal intimin
Stx I B-subunit-expressing Vibrio cholerae vaccine strain [CVD 103-HgR(pDA60)]
Shiga Toxin 1-B subunit and EaeA coexpression from E. Coli in Vibrio cholerae
Shiga Toxin 2 B Subunit Vaccine
CVD 103-HgR Live Oral Cholera Vaccine with E. Coli Cross Protection
S. Typhi engineered to stably express ETEC colonization factor antigen I (CFA/I) vaccine
|
|
4180
|
Csa1A |
Staphylococcus aureus |
|
|
|
4BIH_B
|
|
|
|
|
CDD:282376 |
Csa1A |
Protective antigen |
|
|
4653
|
CSF1R |
Homo sapiens |
|
1436
|
|
569026720
|
|
AC011382 |
NP_001275634 |
|
|
transcript variant 3 |
Protective antigen |
|
|
4686
|
Csf2-Mouse |
Mus musculus |
|
12981
|
|
110625658
|
|
AL596103 |
NP_034099 |
|
|
transcript variant X1 |
Protective antigen |
Vaccinia-GM-CSF Vaccine
|
|
3956
|
csgG |
Haemophilus parasuis SH0165 |
|
|
|
ACL33081
|
|
|
|
|
CDD:224379 |
putative lipoprotein, curli production assembly/transport component CsgG |
Protective antigen |
|
|
4783
|
CSH1 |
Homo sapiens |
|
1442
|
|
4503083
|
|
AC040958 |
NP_001308 |
|
|
chorionic somatomammotropin hormone 1 |
Protective antigen |
hTERT/Survivin/CMV Multipeptide Vaccine
|
|
1743
|
CSP from P. knowlesi |
Plasmodium knowlesi strain H |
|
|
|
221060580
|
|
|
|
|
CDD:319368
EnsemblGenomes-Gn:PKH_134120
EnsemblGenomes-Tr:PKH_134120
GOA:B3LAV3
InterPro: IPR001841
InterPro: IPR013083
UniProtKB/TrEMBL: B3LAV3 |
circumsporozoite protein, putative |
Protective antigen |
P. knowlesi DNA vaccine encoding PkCSP, PkSSP2, PkAMA1, and PkMSP1p42
|
|
3971
|
cssA |
Escherichia coli |
|
16833872
|
|
543130020
|
D616_p104124 |
AB702969 |
YP_008531445 |
|
CDD:293436 |
CS6 structural subunit A |
Protective antigen |
|
|
4563
|
CTAG1B |
Homo sapiens |
|
1485
|
|
4503119
|
|
AC244107 |
NP_001318 |
|
|
cancer/testis antigen 1B |
Protective antigen |
Cancer Subunit NY-ESO-1 Protein Vaccine
Recombinant NY-ESO-1 Protein vaccine adjuvanted with Imiquimod
ALVAC(2) Melanoma Multi-antigen Vaccine
NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine
NY-ESO-1 Peptide Vaccine
NY-ESO-1 Plasmid DNA Cancer Vaccine
NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
NY-ESO-1/GLA-SE Vaccine ID-G305AmN
NY-ESO-1/LAGE-1 Peptide Vaccine
NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine
NY-ESO-1b Peptide Vaccine
NY-ESO-B
Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
Recombinant NY-ESO-1 ISCOMATRIX Vaccine
Recombinant Vaccinia-NY-ESO-1 Vaccine
short overlapping peptides and full-length recombinant protein
12 Melanoma Peptide Vaccine
MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
|
|
4567
|
CTAG2 |
Homo sapiens |
|
30848
|
|
543583752
|
|
AC244107 |
NP_066274 |
|
|
transcript variant 1 |
Protective antigen |
NY-ESO-1/LAGE-1 Peptide Vaccine
Anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes
|
|
710
|
CTLA4 |
Homo sapiens |
|
1493
|
|
83700231
|
|
AC010138 |
NP_001032720 |
1AH1
|
|
transcript variant 1 |
Protective antigen |
Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine
Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant
Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine
ALVAC-hB7.1
GVAX Pancreatic Cancer Vaccine
GVAX Cancer Vaccine
|
|
731
|
ctxB |
|
VO_0011270
|
|
|
110264635
|
|
|
|
|
CDD:279687 |
cholera toxin B |
Protective antigen |
V. cholerae CTB DNA Vaccine
|
|
3832
|
ctxB |
Vibrio cholerae |
|
|
|
AET14210
|
|
|
|
|
CDD:279687 |
CtxB |
Protective antigen |
|
|
4432
|
cupB5 |
Pseudomonas aeruginosa PAO1 |
|
878708
|
|
15599277
|
PA4082 |
AE004091 |
NP_252771 |
|
|
adhesive protein CupB5 |
Protective antigen |
|
|
479
|
CWP2 |
Giardia lamblia ATCC 50803 |
VO_0011080
|
5703171
|
|
159120052
|
GL50803_5435 |
AACB02000001 |
XP_001710242 |
|
|
|
Protective antigen |
G. duodenalis DNA vaccine encoding CWP2
|
|
4840
|
CWP2 |
Giardia intestinalis |
|
5703171
|
|
159120052
|
GL50803_005435 |
AACB03000003 |
XP_001710242 |
|
|
|
Protective antigen |
G. lamblia bivalent DNA vaccine encoding a1-giardin and CWP2
|
|
1001
|
cya |
Salmonella enterica subsp. enterica serovar Typhimurium |
|
|
|
581756
|
|
|
|
|
CDD:193111
GOA:P0A1A7
InterPro: IPR000274
UniProtKB/UniProt: P0A1A7 |
adenylate cyclase |
Virmugen |
Salmonella Typhimurium cya/crp mutant vaccine
|
|
376
|
CyaA |
Bordetella pertussis |
VO_0011031
|
|
|
580668
|
|
|
|
2COL
|
CDD:281494
CDD:280531
CDD:225483
CDD:305016 |
adenylate cyclase |
Protective antigen |
B. pertussis CyaA protein vaccine
|
|
1065
|
cyaA |
Bordetella bronchiseptica RB50 |
|
2661688
|
|
33599313
|
BB0324 |
BX640437 |
NP_886873 |
|
|
bifunctional hemolysin-adenylate cyclase precursor |
Virmugen |
Bordetella bronchiseptica bscN and cyaA double mutant vaccine
|
|
1353
|
CYP1B1 |
Homo sapiens |
|
1545
|
|
189491763
|
|
ABBA01074989 |
NP_000095 |
|
|
cytochrome P450, family 1, subfamily B, polypeptide 1 |
Other |
|
|
483
|
D15 |
Haemophilus influenzae 86-028NP |
VO_0011083
|
3430379
|
|
68249503
|
NTHI1084 |
CP000057 |
YP_248615 |
|
|
protective surface antigen D15 |
Protective antigen |
H. influenzae D15 protein vaccine
|
|
42
|
D8L |
Vaccinia virus (strain: WR (Western Reserve)) |
|
3707569
|
|
|
VACWR113 |
|
|
|
|
|
|
IMV-EEV
|
|
1405
|
D8L |
Vaccinia virus |
|
3707569
|
|
66275910
|
VACWR113 |
DQ121394 |
YP_232995 |
|
|
IMV membrane protein |
Protective antigen |
Vaccinia virus DNA vaccine wtD8L
Vaccinia virus DNA vaccine tPA-D8L
|
|
322
|
dasd |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
841
|
DbpA |
Borrelia burgdorferi 297 |
VO_0012387
|
8319341
|
|
256041910
|
Bbu297_A24 |
U75866 |
YP_003110629 |
|
|
decorin binding protein A |
Protective antigen |
B. burgdorferi DbpA Protein Vaccine
B. burgdorferi DbpA and OspA Protein Vaccine
|
|
4078
|
dbpA |
Borrelia burgdorferi |
|
|
|
ABD95792
|
|
|
|
|
CDD:280507 |
DbpA |
Protective antigen |
|
|
1355
|
DCT |
Homo sapiens |
|
1638
|
|
193788640
|
|
AL139318 |
NP_001123361 |
|
|
transcript variant 1 |
Protective antigen |
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
Murine TYRP2 Plasmid DNA Vaccine
|
|
4685
|
DCT |
Homo sapiens |
|
1638
|
|
193788640
|
|
AL139318 |
NP_001123361 |
|
|
transcript variant X2 |
Protective antigen |
Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
|
|
4462
|
DDR1 |
Homo sapiens |
|
780
|
|
321400059
|
|
AB088102 |
NP_001189450 |
|
|
transcript variant X8 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine
|
|
4009
|
degP |
Edwardsiella tarda |
|
|
|
ADB84596
|
|
|
|
|
CDD:236802
CDD:290102
CDD:238487 |
DegP |
Protective antigen |
|
|
4557
|
DEPDC1 |
Homo sapiens |
|
55635
|
|
166295188
|
|
AL138789 |
NP_001107592 |
|
|
transcript variant 2 |
Protective antigen |
Multipeptide Vaccine S-588210
DEPDC1/MPHOSH1 Peptide Vaccine
|
|
4644
|
DItox |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4063
|
DNA-binding protein |
Campylobacter jejuni |
|
|
|
WP_002867076
|
|
|
|
|
CDD:223854
CDD:153102 |
DNA starvation/stationary phase protection protein |
Protective antigen |
|
|
3867
|
dnaE |
Rickettsia prowazekii str |
|
|
|
NP_221128
|
|
|
|
|
CDD:235554
CDD:213988
CDD:285034
CDD:291259
CDD:239931 |
DNA polymerase III subunit alpha |
Protective antigen |
|
|
728
|
DnaJ |
Salmonella enterica subsp. enterica serovar Typhi str. CT18 |
VO_0011268
|
1246524
|
|
16759006
|
STY0013 |
AL513382 |
NP_454623 |
|
|
DnaJ protein |
Protective antigen |
S. typhi DnaJ Protein Vaccine
|
|
4402
|
DnaJ |
|
|
|
|
WP_001035362
|
|
|
|
|
CDD:331332
CDD:227588
CDD:332379 |
hypothetical protein |
Protective antigen |
S. pneumoniae DnaJ Protein Vaccine
|
|
426
|
dnaK |
Chlamydophila abortus |
VO_0010882
|
|
|
26006347
|
|
|
|
|
CDD:234715 |
DnaK |
Protective antigen |
C. abortus DNA vaccine encoding DnaK
|
|
257
|
DnaK |
Brucella abortus bv. 1 str. 9-941 |
VO_0010970
|
3341115
|
|
62290965
|
BruAb1_2100 |
AE017223 |
YP_222758 |
|
|
molecular chaperone DnaK |
Protective antigen |
|
|
866
|
DnaK |
Mycobacterium tuberculosis H37Rv |
VO_0012408
|
885946
|
|
15607491
|
Rv0350 |
AL123456 |
NP_214864 |
|
|
chaperone protein DnaK |
Protective antigen |
BCG-DHTM
|
|
3961
|
dnaK |
Francisella tularensis |
|
|
|
AAA69561
|
|
|
|
|
CDD:234715
CDD:302596
CDD:212657 |
DnaK |
Protective antigen |
|
|
4012
|
dnaK |
Edwardsiella tarda |
|
|
|
AKH90009
|
|
|
|
|
CDD:234715 |
molecular chaperone DnaK |
Protective antigen |
|
|
416
|
dnaX |
Chlamydophila abortus |
VO_0011056
|
|
|
62148024
|
|
|
|
|
CDD:180523
EnsemblGenomes-Gn:CAB327
EnsemblGenomes-Tr:CAH63776
GOA:Q5L6F0
InterPro: IPR003593
InterPro: IPR008921
InterPro: IPR012763
InterPro: IPR027417
UniProtKB/TrEMBL: Q5L6F0 |
DNA polymerase III subunit gamma/tau |
Protective antigen |
C. abortus DNA vaccine encoding DnaX
|
|
948
|
dnt |
Bordetella pertussis Tohama I |
|
2666936
|
|
33594321
|
BP3439 |
BX640421 |
NP_881965 |
|
|
dermonecrotic toxin |
Virmugen |
Bordetella pertussis dnt mutant vaccine
|
|
1038
|
dnt |
Bordetella bronchiseptica RB50 |
|
2661538
|
|
33602952
|
BB3978 |
BX640449 |
NP_890512 |
|
|
dermonecrotic toxin |
Virmugen |
Bordetella bronchiseptica dnt mutant vaccine
|
|
909
|
drrC |
Mycobacterium tuberculosis H37Rv |
|
888491
|
|
15610075
|
Rv2938 |
BX842581 |
NP_217454 |
|
|
daunorubicin-DIM-transport integral membrane protein ABC transporter DrrC |
Virmugen |
Mycobacterium tuberculosis drrC mutant vaccine
|
|
334
|
dsd |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
554
|
E |
Japanese encephalitis virus |
VO_0011145
|
|
|
16445023
|
|
|
|
|
CDD:279241
CDD:213392
CDD:213897 |
envelope protein |
Protective antigen |
Japanese encephalitis virus vaccine BV-G-E
Japanese encephalitis virus DNA vaccine encoding E protein
Japanese encephalitis virus DNA Vaccine P-JEV
Japanese encephalitis virus DNA Vaccine pCJ-3/E encoding E
NYVAC-JEV- prM/E/ NS1
|
|
669
|
E |
Yellow fever virus Senegal/Ko/HD117294/1995 |
VO_0011252
|
|
|
262283879
|
|
|
|
|
CDD:279241
CDD:280922
CDD:213897 |
envelope glycoprotein |
Protective antigen |
vP869
|
|
1381
|
E |
Dengue virus 1 |
|
|
|
148372385
|
|
|
|
|
CDD:279241
CDD:332896
CDD:213392
CDD:213897 |
envelope protein |
Protective antigen |
Dengue virus DNA vaccine D1ME encoding prM and E
Dengue Virus DNA Vaccine D1ME-VRP
|
|
1382
|
E |
Dengue virus 3 |
|
|
|
166092240
|
|
|
|
|
CDD:279241
CDD:280922
CDD:213897 |
envelope |
Protective antigen |
|
|
1383
|
E |
Dengue virus 4 |
|
|
|
369726339
|
|
|
|
|
CDD:279241
CDD:213392
CDD:213897 |
envelope protein |
Protective antigen |
Dengue Virus DNA Vaccine expressing prM/E proteins
|
|
4275
|
E |
Yellow fever virus |
|
|
|
AAA92706
|
|
|
|
|
CDD:279241
CDD:280922
CDD:213897 |
envelope protein |
Protective antigen |
|
|
4276
|
E |
Tick-borne Encephalitis Virus (TBEV) |
|
|
|
CAC94472
|
|
|
|
|
CDD:279241
CDD:213392
CDD:213897
GOA:Q8UYS5
HSSP: 1SVB
InterPro: IPR000336
InterPro: IPR011998
InterPro: IPR011999
InterPro: IPR013755
InterPro: IPR013756
InterPro: IPR014756
UniProtKB/TrEMBL: Q8UYS5 |
E protein |
Protective antigen |
|
|
590
|
E protein |
|
VO_0011177
|
|
|
111145461
|
|
|
|
2I69
|
CDD:279241
CDD:213392
CDD:213897 |
E protein |
Protective antigen |
West Nile virus DNA vaccine pCBWN encoding prM and E
ALVAC-WNV-PrM/E (dogs and cats)
|
|
780
|
E protein |
|
VO_0011311
|
|
|
202078796
|
|
|
|
1OAN
|
CDD:279241
CDD:213392
CDD:213897 |
envelope protein |
Protective antigen |
Dengue Subunit E Protein Vaccine
Dengue virus DNA vaccine sA encoding prM and E from Dengue Virus 4
Dengue virus DNA vaccine sC encoding prM and E
Dengue virus DNA vaccine sABC encoding prM and E
Dengue virus DNA vaccine pE1D2 encoding E from Dengue Virus 2 strain New Guinea C
Dengue virus DNA vaccine 1040D2MEL encoding dengue-2 prM-E-LAMP chimeric protein
Dengue virus DNA vaccine p1012D2ME encoding prM and E from DEN 2 New Guinea C strain
|
|
1324
|
E protein from West Nile Virus |
West Nile virus NY99 |
|
5714902
|
|
158516888
|
WNVNY99_gp1 |
DQ211652 |
YP_001527877 |
|
|
polyprotein |
Other |
|
|
966
|
E(rns) |
Classical swine fever virus - Brescia |
|
|
|
130457
|
|
|
|
|
CDD:147625
CDD:152325
CDD:185828
CDD:29472
CDD:152822
CDD:114308
CDD:31829
CDD:28927
CDD:73158 |
Genome polyprotein |
Virmugen |
Classical swine fever virus E(rns) mutant vaccine
|
|
443
|
E0 |
|
VO_0010898
|
|
|
115343287
|
|
|
|
|
CDD:294141
CDD:238220 |
envelope glycoprotein E0 |
Protective antigen |
Classical swine fever virus vaccine VAC-E0
|
|
965
|
E1 |
Classical swine fever virus - Brescia |
|
|
325460
|
325461
|
|
|
AAA43843.1 |
|
|
envelope glycoprotein E1 |
Virmugen |
Classical swine fever virus E1 mutant vaccine
|
|
774
|
E1 |
Western equine encephalomyelitis virus |
VO_0011306
|
|
17148716
|
17148717
|
|
|
AAL35792.1 |
|
CDD:279870 |
glycoprotein |
Protective antigen |
WEEV DNA Vaccine encoding 6K-E1 Protein
Western equine encephalomyelitis virus PE2/E1 mutant vaccine
|
|
4272
|
E1 |
Rubella virus |
|
|
|
BAB88324
|
|
|
|
|
CDD:283418 |
E1 |
Protective antigen |
|
|
4332
|
E1 |
Hepatitis C virus |
|
|
|
AAO46051
|
|
|
|
|
CDD:110536
CDD:110557 |
E1 |
Protective antigen |
|
|
727
|
E1 glycoprotein |
Venezuelan equine encephalitis virus |
VO_0011267
|
|
|
798795
|
|
|
|
|
CDD:201874 |
E1 glycoprotein |
Protective antigen |
VEE Virus PE2/E1 mutant vaccine
VEE virus DNA vaccine VEEV IA/B parent encoding structural genes
|
|
4246
|
E1 protein |
Eastern Equine Encephalitis Virus |
|
|
|
NP_740648
|
|
|
|
|
CDD:279870 |
E1 protein |
Protective antigen |
|
|
4285
|
E1 protein |
Western equine encephalomyelitis virus |
|
|
|
NP_818942
|
|
|
|
|
CDD:279870 |
E1 protein |
Protective antigen |
|
|
4659
|
E1B |
Human mastadenovirus C |
|
2652981
|
|
9626162
|
HAdVC_gp02 |
JX173077 |
NP_040510 |
|
|
control protein E1B 19K |
Protective antigen |
|
|
442
|
E2 |
Classical swine fever virus strain LPC |
VO_0010897
|
|
|
50403916
|
|
|
|
|
CDD:292945 |
E2 protein |
Protective antigen |
Classical swine fever virus vaccine VAC-E2
|
|
773
|
E2 |
Western equine encephalomyelitis virus |
VO_0011305
|
|
|
29611992
|
|
|
|
|
CDD:279311 |
E2 protein |
Protective antigen |
WEEV Subunit E2 Protein Vaccine
Western equine encephalomyelitis virus PE2/E2 mutant virus
|
|
1032
|
E2 |
Classical swine fever virus |
|
920146
|
|
12657942
|
PestiV2gp1 |
AF326963 |
NP_075354 |
|
|
polyprotein |
Virmugen |
Classical swine fever virus E2 mutant vaccine
Classical swine fever virus DNA vaccine pCI-gp55
DNA vaccine expressing the E2 protein
Classical Swine Fever Virus DNA Vaccine pcDNA/E2 with TRIF
rORFV-CSFV-E2
|
|
1410
|
E2 |
Sindbis virus |
|
|
|
20257395
|
|
|
|
|
CDD:279311 |
polyprotein |
Protective antigen |
Sindbis virus DNA vaccine encoding E2
|
|
1662
|
E2 |
Classical swine fever virus strain Shimen |
|
|
|
221063268
|
|
|
|
|
CDD:292945 |
E2 glycoprotein |
Protective antigen |
|
|
1679
|
E2 |
Bovine viral diarrhea virus 2 TC Shinozaki NCP/92 |
|
|
|
49614538
|
|
|
|
|
CDD:292945 |
structural glycoprotein E2 |
Protective antigen |
BVDV DNA vaccine encoding E2
|
|
4267
|
E2 |
Human Papillomavirus |
|
|
|
ATD50852
|
|
|
|
|
CDD:278909
CDD:317681
CDD:278912 |
E2 protein |
Protective antigen |
|
|
4331
|
E2 |
Hepatitis C virus |
|
|
|
AAB30986
|
|
|
|
|
CDD:110557 |
E2 |
Protective antigen |
|
|
725
|
E2 envelope protein |
Venezuelan equine encephalitis virus |
VO_0011265
|
|
|
25140296
|
|
|
|
|
CDD:279311 |
E2 envelope protein |
Protective antigen |
VEE virus DNA vaccine VEEV IA/B parent encoding structural genes
|
|
4245
|
E2 protein |
Eastern Equine Encephalitis Virus |
|
|
|
AAL09089
|
|
|
|
|
CDD:279311 |
E2 protein |
Protective antigen |
|
|
4257
|
E2 protein |
Bovine viral diarrhea virus 1 |
|
|
|
ABW24687
|
|
|
|
|
CDD:292945 |
E2 protein |
Protective antigen |
|
|
4335
|
E2 protein |
chikungunya virus |
|
|
|
AEJ18140
|
|
|
|
|
CDD:279311 |
E2 protein |
Protective antigen |
|
|
1684
|
E2A |
Mus musculus |
|
21423
|
|
255918153
|
|
AB095606 |
NP_001157619 |
|
|
transcript variant 8 |
Protective antigen |
Carcinoma DNA vaccine pVAX/E2A
|
|
4244
|
E3 protein |
Eastern Equine Encephalitis Virus |
|
|
|
NP_740645
|
|
|
|
|
CDD:279849 |
E3 protein |
Protective antigen |
|
|
4286
|
E3 protein |
Western equine encephalomyelitis virus |
|
|
|
NP_818939
|
|
|
|
|
CDD:279849 |
E3 protein |
Protective antigen |
|
|
511
|
E6 |
Human papillomavirus type 16 |
VO_0011107
|
1489078
|
|
9627104
|
HpV16gp1 |
AB663688 |
NP_041325 |
|
|
transforming protein E6 |
Protective antigen |
Human papillomavirus DNA vaccine pNGVL4a-E6/opt
Human papillomavirus DNA vaccine hCRTE6E7L2 DNA encoding CRT linked to E6, E7 and L2
|
|
4268
|
E6 |
Human Papillomavirus |
|
|
|
AAP20594
|
|
|
|
|
CDD:332494 |
E6 protein |
Protective antigen |
|
|
4489
|
E6 |
Human papillomavirus type 16 |
|
1489078
|
|
9627104
|
HpV16gp1 |
AB663688 |
NP_041325 |
|
|
transforming protein E6 |
Protective antigen |
Amolimogene Bepiplasmid
Human Papillomavirus Tumor Antigen Vaccine
HPV DNA Plasmids Therapeutic Vaccine VGX-3100
Recombinant Vaccinia Viral Vector RO5217790
rMVTT- HPV16-E6/E7
Synthetic Long E6/E7 Peptides Vaccine HPV-01
DNA Vaccine VB10.16
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112
HPV 16 E6 (18-26) Peptide Vaccine
Host Dendritic Cell Vaccine-001 MSSM/BIIR
|
|
509
|
E7 |
Human papillomavirus type 16 |
VO_0011105
|
1489079
|
|
9627105
|
HpV16gp2 |
AB663783 |
NP_041326 |
|
|
transforming protein E7 |
Protective antigen |
Human papillomavirus E7 protein vaccine
Human papillomavirus DNA vaccine Pe7(pcDNA3-Sig/sE7/LAMP) encoding E7
Human papillomavirus DNA vaccine CRT/E7 DNA
Human papillomavirus DNA vaccine E7IR
Human papillomavirus DNA vaccine E7SH DNA
Human papillomavirus DNA vaccine hCRTE6E7L2 DNA encoding CRT linked to E6, E7 and L2
LM1-2-E7
|
|
4269
|
E7 |
Human Papillomavirus |
|
|
|
AAP20595
|
|
|
|
|
CDD:295537 |
E7 protein |
Protective antigen |
|
|
4490
|
E7 |
Human papillomavirus type 16 |
|
1489079
|
|
9627105
|
HpV16gp2 |
AB663783 |
NP_041326 |
|
|
transforming protein E7 |
Protective antigen |
Amolimogene Bepiplasmid
Human Papillomavirus Tumor Antigen Vaccine
HPV DNA Plasmids Therapeutic Vaccine VGX-3100
HPV 16 E7:86-93 Peptide Vaccine
HPV 16 E7:12-20 Peptide Vaccine
Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
pNGVL4a-CRT/E7(detox) DNA Vaccine
pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine
Recombinant Vaccinia Viral Vector RO5217790
rMVTT- HPV16-E6/E7
Synthetic Long E6/E7 Peptides Vaccine HPV-01
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112
Cancer Vaccine using E7 protein of human papillomavirus 16 and Quil-A
Cancer Vaccine using E7 protein of human papillomavirus 16 and Algammulin
attenuated Listeria expressing cancer antigen vaccine
DNA Vaccine VB10.16
Human Papillomavirus 16 E7 Peptide/Padre 965.10 Vaccine
Verpasep Caltespen
|
|
93
|
eae |
Escherichia coli O157:H7 str. EDL933 |
VO_0010944
|
960862
|
|
WP_129935252
|
Z5110 |
AE005174 |
NP_290259 |
1E5U
|
|
intimin |
Protective antigen |
E. coli vaccine using intimin polypeptide
E. coli subunit vaccine based on intimin and Efa-1 polypeptides
|
|
835
|
eba-175 |
Plasmodium falciparum 3D7 |
VO_0012382
|
2654998
|
|
296004911
|
PF3D7_0731500 |
AL844506 |
XP_001349207 |
|
|
|
Protective antigen |
P. falciparum DNA Vaccine encoding EBA-175
|
|
4561
|
EBNA-1 |
Human gammaherpesvirus 4 |
|
3783709
|
|
82503233
|
HHV4_EBNA-1.1 |
AB850647 |
YP_401677 |
|
|
mRNA |
Protective antigen |
MVA-EBNA1/LMP2 Vaccine
|
|
11
|
EBOV NP |
Reston ebolavirus |
VO_0010859
|
955194
|
|
22789223
|
REBOVgp1 |
AF522874 |
NP_690580 |
|
|
mRNA |
Protective antigen |
NP-VRP
|
|
1326
|
EF |
Bacillus anthracis |
|
|
|
142813
|
|
|
|
|
CDD:149028
CDD:202671 |
edema factor |
Other |
|
|
85
|
efa1 |
Escherichia coli O157:H7 |
|
916316
|
|
WP_001239095
|
ECs3860 |
NC_002695 |
NP_311887 |
|
CDD:315573
CDD:327708 |
cytotoxin |
Protective antigen |
E. coli subunit vaccine based on intimin and Efa-1 polypeptides
E. coli subunit vaccine based on Efa-1 polypeptide
|
|
1732
|
efb |
Staphylococcus aureus subsp. aureus VRS11b |
|
|
|
387748005
|
|
|
|
|
CDD:192953 |
extracellular fibrinogen-binding protein Efb |
Protective antigen |
S. aureus DNA vaccine encoding Efb, FnbpA, ClfA, Cna
|
|
4413
|
EGFR |
Homo sapiens |
|
1956
|
|
1100818972
|
|
AB221348 |
NP_001333826 |
|
|
transcript variant 1 |
Protective antigen |
PF-04948568
Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1
Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
PEP-3-KLH Conjugate Vaccine
Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701
EGFRvIII Peptide Vaccine
|
|
798
|
ELI-Ag1 |
Coccidioides immitis |
VO_0011329
|
|
|
37779128
|
|
|
|
|
|
expression library immunization antigen 1 |
Protective antigen |
|
|
92
|
eltB |
Escherichia coli |
VO_0010943
|
|
|
157021162
|
|
|
|
1PZI
|
CDD:279687 |
LTB |
Protective antigen |
soybean-expressed E. coli LTB vaccine
|
|
4791
|
Emb |
Mus musculus |
|
13723
|
|
226437629
|
|
AC123935 |
NP_034460 |
|
|
embigin |
Protective antigen |
|
|
4107
|
emm |
Streptococcus pyogenes |
|
|
|
AAN04081
|
|
|
|
|
CDD:235600
CDD:274008 |
M24 |
Protective antigen |
|
|
854
|
emm1 |
Streptococcus pyogenes |
VO_0012397
|
|
311757
|
311758
|
|
|
CAA44062.1 |
2OTO
|
CDD:273479
CDD:291694
CDD:295219
CDD:279132
GOA:Q10372
HSSP: 1IC2
InterPro: IPR001899
InterPro: IPR005877
InterPro: IPR019931
InterPro: IPR019948
InterPro: IPR019950
UniProtKB/TrEMBL: Q10372 |
M protein type 1 |
Protective antigen |
S. pyogenes M Protein Vaccine
|
|
4112
|
emm12 mutant |
Streptococcus pyogenes |
|
|
|
BAD14986
|
|
|
|
|
ATCC:12353
CDD:273479
CDD:302792
CDD:303051
CDD:287450
CDD:295219 |
M12 mutant protein precursor |
Protective antigen |
|
|
4115
|
emm3 |
Streptococcus pyogenes |
|
|
|
CAA56449
|
|
|
|
|
CDD:273479
CDD:303051
CDD:287450
CDD:287215
CDD:279132
GOA:Q54835
InterPro: IPR001899
InterPro: IPR005877
InterPro: IPR019931
InterPro: IPR019948
InterPro: IPR019950
UniProtKB/TrEMBL: Q54835 |
M3 protein |
Protective antigen |
|
|
4157
|
endopeptidase O(PepO) |
Streptococcus pneumoniae |
|
|
|
EJG73599
|
|
|
|
|
|
endopeptidase O |
Protective antigen |
|
|
721
|
Eng |
Mus musculus |
|
13805
|
|
226437649
|
RP23-17P12.4 |
AL772271 |
NP_001139820 |
|
|
transcript variant 2 |
Protective antigen |
Cancer DNA Vaccine encoding Endoglin Boosted with Recombinant Endoglin Protein
|
|
4756
|
ENG |
Homo sapiens |
|
2022
|
|
4557555
|
|
AF035753 |
NP_000109 |
|
|
transcript variant 2 |
Protective antigen |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
|
|
4025
|
enhA1 |
Coxiella burnetii Q321] |
|
|
|
EDR35563
|
|
|
|
|
|
enhanced entry protein EnhA |
Protective antigen |
|
|
4044
|
eno |
Chlamydia trachomatis |
|
|
|
AKR39796
|
|
|
|
|
CDD:213580 |
enolase |
Protective antigen |
|
|
4209
|
eno |
Streptococcus agalactiae |
|
|
|
AFV72009
|
|
|
|
|
CDD:234617 |
Enolase |
Protective antigen |
|
|
4035
|
enolase |
Chlamydophila pneumoniae |
|
|
|
AAP98758
|
|
|
|
|
CDD:213580
CDD:239429 |
enolase |
Protective antigen |
|
|
4191
|
entA_1 |
Staphylococcus aureus subsp. aureus SK1585 |
|
|
|
KFD31781
|
|
|
|
|
|
sea |
Protective antigen |
|
|
153
|
env |
Human immunodeficiency virus 1 |
VO_0010937
|
|
|
8218033
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369
GOA:Q9IBN3
HSSP: 1MEQ
InterPro: IPR000328
InterPro: IPR000777
UniProtKB/TrEMBL: Q9IBN3 |
ENV (gp160) |
Protective antigen |
HIV priming with DNA vaccine expressing HIV gp160 protein and boosted with Ad5/35 vector expressing the same protein
DNA vaccine expressing multiple HIV epitopes
|
|
1240
|
env |
Human immunodeficiency virus 1 |
|
155971
|
|
9629363
|
HIV1gp8 |
AF033819 |
NP_057856 |
|
|
Envelope surface glycoprotein gp160, precursor |
Protective antigen |
HIV DNA vaccine env-pcDNA3.1 encoding env
Combination of HIV DNA vaccine pCMV HIV gag and pCMV HIV gp120 and gp140
HIV DNA vaccine ALVAC-HIV encoding env, gag, and pro
HIV adnenovirus vector vaccine Ad28 encoding env, gag, and pro
HIV DNA vaccine Ad26/Ad5HVR48 encoding HIV or SIV env or gag
HIV DNA vaccine HIV DNA encoding gp160
HIV DNA vaccine pHIS-SHIV-B
HIV recombinant vector vaccine MVA.HIVA encoding env and rev
HIV priming with DNA vaccine expressing HIV gp160 protein and boosted with Ad5/35 vector expressing the same protein
ALVAC-HIV-2- env/gag/pol
|
|
1243
|
env |
Simian immunodeficiency virus |
|
|
|
532231
|
|
|
|
|
CDD:109567
CDD:197369 |
envelope glycoprotein |
Other |
SIV DNA vaccine pVacc4 encoding env from mac239
SabRV-SIV
|
|
1251
|
env |
Human immunodeficiency virus 1 |
|
|
|
169641099
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
|
|
1261
|
env |
Human immunodeficiency virus 1 MN |
|
|
|
3342812
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
HIV DNA vaccine APL 400–003 encoding env and rev
HIV DNA vaccine pCMN160
|
|
1266
|
env |
Human immunodeficiency virus 1 |
|
|
|
58043865
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
|
|
1273
|
env |
Human immunodeficiency virus 1 |
|
|
|
1129018
|
|
|
|
|
CDD:278917 |
envelope glycoprotein gp120 |
Protective antigen |
|
|
1708
|
env |
Simian-Human immunodeficiency virus strain SHIV89.6P |
|
|
|
72398919
|
|
|
|
|
CDD:278917 |
envelope protein |
Protective antigen |
DNA and poxvirus priming-boosting SHIV vaccine
HIV DNA vaccine SIVmac239 Gag-Pol-Nef and mock Env with rAd5 boost
|
|
1711
|
env |
Simian-Human immunodeficiency virus strain SHIV-89.6 |
|
|
|
2828045
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
env |
Protective antigen |
HIV DNA vaccine SHIV-89.6 DNA (DNA/89.6)
|
|
1720
|
env |
Human immunodeficiency virus 2 |
|
|
|
1845209
|
|
|
|
|
CDD:278917
CDD:278918
CDD:197369 |
envelope polyprotein |
Protective antigen |
HIV-2 DNA vaccine
ALVAC-HIV-2
|
|
1738
|
env |
Reticuloendotheliosis virus strain APC-566 |
|
|
|
88605105
|
|
|
|
|
CDD:278837
CDD:197368 |
env protein |
Protective antigen |
REV DNA vaccine VP22/gag and VP22/env
|
|
1747
|
env |
Human immunodeficiency virus 1 isolate 715 from Baltimore clone 6 |
|
|
|
475647
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
SHIV DNA vaccine encoding env and gag
SHIV(Ba-L) DNA vaccine encoding env and gag
|
|
1748
|
env |
Human immunodeficiency virus 1 strain Ba-L subtype B |
|
|
326367
|
326371
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
|
Protective antigen |
SHIV DNA vaccine encoding env and gag
SHIV(Ba-L) DNA vaccine encoding env and gag
|
|
1749
|
env |
Human immunodeficiency virus 1 strain 96ZM651 |
|
|
|
13569225
|
|
|
|
|
CDD:278917
CDD:197369 |
envelope glycoprotein |
Protective antigen |
SHIV DNA vaccine encoding env and gag
SHIV(Ba-L) DNA vaccine encoding env and gag
|
|
1750
|
env |
Human immunodeficiency virus 1 strain 976 clone 17 |
|
|
|
475668
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
SHIV DNA vaccine encoding env and gag
SHIV(Ba-L) DNA vaccine encoding env and gag
|
|
1752
|
env |
Human immunodeficiency virus 1 isolate 037 clone 08 |
|
|
|
487257
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
SHIV(Ba-L) DNA vaccine encoding env and gag
|
|
1753
|
env |
Simian-Human immunodeficiency virus |
|
|
|
343533448
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
|
|
4249
|
env |
Feline herpesvirus 1 |
|
|
|
BAA12690
|
|
|
|
|
CDD:150302 |
env, partial [Feline immunodeficiency virus] |
Protective antigen |
|
|
4280
|
env |
Bovine Leukemia virus |
|
|
|
BAV53924
|
|
|
|
|
|
gp51 |
Protective antigen |
|
|
4709
|
env |
Human immunodeficiency virus 1 |
|
155971
|
|
9629363
|
HIV1gp8 |
AF033819 |
NP_057856 |
|
|
Envelope surface glycoprotein gp160, precursor |
Protective antigen |
HIVgP160 Vaccine
AUT-OV-ALVAC-hB7.1 Vaccine
|
|
1411
|
env from FeLV-A/Glasgow |
Feline leukemia virus |
|
|
|
546071
|
|
|
|
|
CDD:278837 |
gp70 |
Protective antigen |
FeLV DNA vaccine gag/pol and env
ALVAC-FL- env/gag
|
|
1250
|
env from SIV |
Simian immunodeficiency virus |
|
1490007
|
|
9627208
|
SIVgp6 |
M58410 |
NP_054372 |
|
|
envelope protein |
Protective antigen |
HIV DNA vaccine Ad26/Ad5HVR48 encoding HIV or SIV env or gag
rMVTT-SIV-gpe
|
|
465
|
Env from strain FRA |
Feline leukemia virus |
VO_0011068
|
1491868
|
|
9630709
|
FeLVgp2 |
AF052723 |
NP_047256 |
|
|
Env polyprotein |
Protective antigen |
EURIFEL FeLV
|
|
1254
|
env HIV |
Human immunodeficiency virus 1 |
|
155971
|
|
9629363
|
HIV1gp8 |
AF033819 |
NP_057856 |
|
|
Envelope surface glycoprotein gp160, precursor |
Other |
|
|
1244
|
env receptor binding subunit |
Simian immunodeficiency virus |
|
|
|
603752
|
|
|
|
|
CDD:109567 |
envelope glycoprotein gp120 receptor binding subunit |
Other |
SabRV-SIV
|
|
411
|
Env/Rex/Tax |
Bovine leukemia virus |
VO_0011051
|
2760849
|
|
9626230
|
BLVgp05 |
AF033818 |
NP_056898 |
|
|
p18 |
Protective antigen |
Bovine leukemia virus DNA vaccine encoding Env
|
|
496
|
envelope |
Hepatitis B virus |
VO_0011094
|
|
|
113207330
|
|
|
|
|
CDD:279085
GOA:Q0KG42
InterPro: IPR000349
UniProtKB/TrEMBL: Q0KG42 |
preS2 middle surface protein |
Protective antigen |
Hepatitis B virus DNA vaccine pVAX-PS
|
|
4809
|
envelope (E) protein |
Severe acute respiratory syndrome coronavirus 2 |
|
43740570
|
|
1796318600
|
GU280_gp04 |
LC528232 |
YP_009724392 |
|
|
envelope protein |
Protective antigen |
|
|
4262
|
envelope (E) proteins |
Japanese encephalitis virus |
|
|
|
P27395
|
|
|
|
|
CDD:250285
CDD:279856
CDD:279358
CDD:279241
CDD:213392
CDD:213897
CDD:279316
CDD:279359
CDD:279357
CDD:279317
CDD:214692
CDD:284962
CDD:238005
CDD:304359
CDD:238034
CDD:279666
CDD:279665
CDD:279986
CDD:279336 |
Genome polyprotein |
Protective antigen |
|
|
1242
|
Envelope polyprotein from HXB2 |
Human immunodeficiency virus 1 |
|
|
|
1906385
|
|
|
|
|
CDD:278917
CDD:278918
CDD:197369 |
|
Protective antigen |
|
|
915
|
envelope protein (E) gene of SARS-CoV |
Severe acute respiratory syndrome-related coronavirus |
|
1489671
|
|
29836499
|
sars4 |
|
NP_828854 |
|
|
protein E |
Virmugen |
SARS-CoV E gene mutant vaccine
rMA15-ΔE vaccine
|
|
1072
|
envZ |
Shigella flexneri 5 str. 8401 |
|
4207729
|
|
110807236
|
SFV_3409 |
CP000266 |
YP_690756 |
2LFR
|
|
osmolarity sensor protein |
Virmugen |
Shigella flexneri envZ mutant vaccine
|
|
4320
|
EP153R |
African Swine Fever Virus |
|
|
|
AJZ77151
|
|
|
|
|
CDD:214480 |
EP153R |
Protective antigen |
|
|
317
|
EPCAM |
Homo sapiens |
|
4072
|
|
218505670
|
|
AC079775 |
NP_002345 |
|
|
epithelial cell adhesion molecule |
Protective antigen |
Cancer EPCAM protein vaccine
KSA-KLH Conjugate Vaccine
Recombinant Colorectal cancer antigen GA733 Vaccine
|
|
4525
|
EPHA2 |
Homo sapiens |
|
1969
|
|
1041818018
|
|
AL451042 |
NP_001316019 |
|
|
transcript variant 2 |
Protective antigen |
HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
|
|
296
|
ERBB2 |
Homo sapiens |
|
2064
|
|
54792098
|
RP23-355L10.8 |
AB025285 |
NP_001005862 |
|
|
transcript variant 3 |
Protective antigen |
Cancer Her-2/neu Protein Subunit Vaccine
Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine
AE37 Peptide/GM-CSF Vaccine
HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
HER2-pulsed Autologous Type-1 Polarized Dendritic Cell Vaccine
HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901
Monoclonal Antibody 4B5 Anti-Idiotype Vaccine
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
MVF-HER-2(597-626)/MVF-HER-2 (266-296) Peptide Vaccine
Nelipepimut-S Plus GM-CSF Vaccine
EP-2101
pNGVL3-hICD Vaccine
Poly Microsphere Encapsulated HER2/neu Oral Vaccine
Recombinant dHER2 Vaccine
Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine
Allogeneic GM-CSF-Secreting Breast Cancer Vaccine
Autologous GM-CSF-Secreting Breast Cancer Vaccine
Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine
Lapuleucel-T Vaccine
CD80 Breast Cancer Vaccine
Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
Mammaglobin-A DNA Vaccine
|
|
4731
|
Erbb2 |
Rattus norvegicus |
|
24337
|
|
77020289
|
|
AABR07030444 |
NP_058699 |
|
|
erb-b2 receptor tyrosine kinase 2 |
Protective antigen |
Adenovirus Encoding Rat HER-2/neu
|
|
1693
|
esa1 |
Edwardsiella tarda strain TX1 |
|
|
|
302136428
|
|
|
|
|
CDD:236834
CDD:284624
CDD:279448 |
putative surface antigen |
Protective antigen |
E. tarda DNA vaccine pCEsa1
|
|
4003
|
eseC |
Edwardsiella tarda EIB201 |
|
|
|
AAV69404
|
|
|
|
|
CDD:237952 |
EseC |
Protective antigen |
|
|
4008
|
eseD |
Edwardsiella tarda |
|
|
|
AAV69405
|
|
|
|
|
CDD:185259 |
EseD |
Protective antigen |
|
|
3977
|
espA |
Escherichia coli O157:H7 |
|
|
|
EIP05353
|
|
|
|
|
|
espA |
Protective antigen |
EspA-Tir-M novel fusion protein vaccine
|
|
3987
|
espB |
Escherichia coli O157:H7 |
|
|
|
EIP05354
|
|
|
|
|
|
espB |
Protective antigen |
|
|
1057
|
esrB |
Edwardsiella tarda EIB202 |
|
8607237
|
|
269138242
|
ETAE_0886 |
CP001135 |
YP_003294942 |
|
|
two-component response regulator EsrB, LuxR family |
Virmugen |
Edwardsiella tarda esrB mutant vaccine
|
|
1092
|
esrC |
Edwardsiella tarda EIB202 |
|
8607212
|
|
269138217
|
ETAE_0861 |
CP001135 |
YP_003294917 |
|
|
putative transcriptional regulator EsrC |
Virmugen |
Edwardsiella tarda aroC/esrC mutant vaccine
|
|
4176
|
esxA |
Staphylococcus aureus |
|
|
|
A0A0H2XI99
|
|
|
|
|
CDD:227179 |
ESAT-6 secretion system extracellular protein A |
Protective antigen |
|
|
104
|
EsxA (ESAT-6) |
Mycobacterium tuberculosis H37Rv |
VO_0010919
|
886209
|
|
57117165
|
Rv3875 |
AL123456 |
YP_178023 |
|
EMBL: AE000516
EMBL: AF004671
EMBL: AF420491
EMBL: BX842584
EMBL: X79562
GenomeReviews: AE000516_GR
GenomeReviews: AL123456_GR
InterPro: IPR010310
KEGG: mtc:MT3989
KEGG: mtu:Rv3875
PDB: 1WA8
Pfam: PF06013
PIR: A70803
TIGR: MT3989
TubercuList: Rv3875
UniProt: P0A564 |
ESAT-6 protein EsxA |
Protective antigen |
recombinant S. typhimurium secreting M. tuberculosis ESAT-6
Ag85B and ESAT-6 fusion protein
MVA/IL-15/5Mtb vaccine
|
|
121
|
EsxB |
Mycobacterium tuberculosis H37Rv |
VO_0010951
|
886194
|
|
15611010
|
Rv3874 |
AF004671 |
NP_218391 |
3FAV
|
EMBL: AE000516
EMBL: AF004671
EMBL: AF419854
EMBL: BX842584
GenomeReviews: AE000516_GR
GenomeReviews: AL123456_GR
InterPro: IPR010310
KEGG: mtc:MT3988
KEGG: mtu:Rv3874
Pfam: PF06013
PIR: H70802
SMR: P0A566
TIGR: MT3988
TubercuList: Rv3874
UniProt: P0A566 |
ESAT-6-like protein EsxB |
Protective antigen |
|
|
4177
|
esxB |
Staphylococcus aureus |
|
|
|
A0A0H2XIE9
|
|
|
|
|
CDD:310537 |
ESAT-6 secretion system extracellular protein B |
Protective antigen |
|
|
4396
|
esxV |
Mycobacterium tuberculosis H37Rv |
|
|
|
